http://crossborderbiotech.ca/2012/06/01/friday-science-review-june-1-2012/2012-05-31T17:57:05+00:00monthlyhttp://crossborderbiotech.ca/2012/05/25/friday-science-review-may-25-2012/2012-05-25T04:06:57+00:00monthlyhttp://crossborderbiotech.ca/2012/05/24/q1-2012-in-canadian-healthcare/2012-05-24T15:36:45+00:00monthlyhttp://crossborderbiotech.ca/2012/05/18/friday-science-review-may-18-2012/2012-05-16T15:55:48+00:00monthlyhttp://crossborderbiotech.ca/2012/05/14/monday-biotech-deal-review-may-14-2012/2012-05-14T18:33:47+00:00monthlyhttp://crossborderbiotech.ca/2012/05/11/friday-science-review-may-11-2012/2012-05-09T20:07:57+00:00monthlyhttp://crossborderbiotech.ca/2012/05/09/biotech-partnering-process-deal-structure-part-18-of-valuation-and-other-biotech-mysteries/2012-05-08T15:32:05+00:00monthlyhttp://crossborderbiotech.ca/2012/05/07/monday-biotech-deal-review-may-7-2012/2012-05-08T15:27:27+00:00monthlyhttp://crossborderbiotech.ca/2012/05/04/friday-science-review-may-4-2012/2012-05-04T03:10:42+00:00monthlyhttp://crossborderbiotech.ca/2012/05/03/healthcare-in-the-u-s-the-new-normal/2012-05-04T03:07:35+00:00monthlyhttp://crossborderbiotech.ca/2012/04/30/monday-biotech-deal-review-april-30-2012/2012-04-30T22:47:21+00:00monthlyhttp://crossborderbiotech.ca/2012/04/27/friday-science-review-april-27-2012/2012-04-27T13:46:30+00:00monthlyhttp://crossborderbiotech.ca/2012/04/20/friday-science-review-20-april-2012/2012-04-27T13:46:01+00:00monthlyhttp://crossborderbiotech.ca/2012/04/13/friday-science-review-13-april-2012/2012-04-27T13:45:30+00:00monthlyhttp://crossborderbiotech.ca/2012/04/06/friday-science-review-6-april-2012/2012-04-27T13:44:24+00:00monthlyhttp://crossborderbiotech.ca/2012/04/24/deloitte-and-thomson-reuters-follow-up-on-rd-value/2012-04-24T19:44:00+00:00monthlyhttp://crossborderbiotech.ca/about/2012-04-24T19:32:33+00:00weekly0.6http://crossborderbiotech.ca/2012/04/23/monday-biotech-deal-review-april-23-2012/2012-04-24T01:30:07+00:00monthlyhttp://crossborderbiotech.ca/2012/04/16/monday-biotech-deal-review-april-16-2012/2012-04-17T19:05:49+00:00monthlyhttp://crossborderbiotech.ca/2012/04/02/monday-biotech-deal-review-april-2-2012/2012-04-02T16:25:43+00:00monthlyhttp://crossborderbiotech.ca/2012/03/30/7156/2012-04-02T12:31:04+00:00monthlyhttp://crossborderbiotech.ca/2012/03/23/friday-science-review-march-23-2012/2012-03-23T02:14:09+00:00monthlyhttp://crossborderbiotech.ca/2012/03/16/friday-science-review-march-16-2012/2012-03-18T05:03:45+00:00monthlyhttp://crossborderbiotech.ca/2012/03/14/the-partnering-process-before-crunching-the-numbers-part-17-of-valuation-and-other-biotech-mysteries/2012-03-12T18:46:20+00:00monthlyhttp://crossborderbiotech.ca/2012/03/12/monday-biotech-deal-review-march-12-2012/2012-03-12T18:35:47+00:00monthlyhttp://crossborderbiotech.ca/trends-in-2009/2012-03-12T14:24:52+00:00weekly0.6http://crossborderbiotech.ca/2012/03/09/friday-science-review-march-9-2012/2012-03-09T16:59:50+00:00monthlyhttp://crossborderbiotech.ca/2012/03/02/friday-science-review-march-2-2012/2012-03-02T04:12:50+00:00monthlyhttp://crossborderbiotech.ca/2012/02/24/friday-science-review-february-24-2012/http://testbio.files.wordpress.com/2012/02/jh_profile.pngJohn Holyoake2012-02-24T04:13:42+00:00monthlyhttp://crossborderbiotech.ca/2012/02/13/monday-biotech-deal-review-february-13-2012/2012-02-14T03:57:23+00:00monthlyhttp://crossborderbiotech.ca/2012/02/15/biotech-licensing-basics-part-16-of-valuation-and-other-biotech-mysteries/2012-02-13T20:49:52+00:00monthlyhttp://crossborderbiotech.ca/2012/02/10/friday-science-review-february-10-2012/2012-02-10T00:42:46+00:00monthlyhttp://crossborderbiotech.ca/2012/02/03/friday-science-review-february-3-2012/2012-02-03T18:44:45+00:00monthlyhttp://crossborderbiotech.ca/2012/02/01/partner-sell-or-go-it-alone-part-15-of-valuation-and-other-biotech-mysteries/2012-01-31T21:35:27+00:00monthlyhttp://crossborderbiotech.ca/2012/01/30/monday-biotech-deal-review-january-30-2012/2012-01-30T16:23:33+00:00monthlyhttp://crossborderbiotech.ca/2012/01/27/friday-science-review-january-27-2011/2012-01-27T14:08:27+00:00monthlyhttp://crossborderbiotech.ca/2012/01/23/monday-biotech-deal-review-january-23-2012/2012-01-23T14:45:55+00:00monthlyhttp://crossborderbiotech.ca/2012/01/20/friday-science-review-january-20-2012/2012-01-20T03:04:53+00:00monthlyhttp://crossborderbiotech.ca/2012/01/16/monday-biotech-deal-review-january-16-2012/2012-01-16T16:15:11+00:00monthlyhttp://crossborderbiotech.ca/2012/01/13/6991/2012-01-13T16:06:40+00:00monthlyhttp://crossborderbiotech.ca/2012/01/09/monday-biotech-deal-review-january-9-2012/2012-01-10T01:48:32+00:00monthlyhttp://crossborderbiotech.ca/2012/01/09/canada-biotech-numbers-2011-for-public-canadian-healthcare/http://testbio.files.wordpress.com/2012/01/equicom-2011-ye-fig-1.jpgEquicom 2011 YE Fig 12012-01-09T16:28:41+00:00monthlyhttp://crossborderbiotech.ca/2012/01/06/friday-science-review-january-6-2012/2012-01-05T18:39:46+00:00monthlyhttp://crossborderbiotech.ca/2011/12/30/friday-science-review-december-30-2011/2011-12-30T17:03:24+00:00monthlyhttp://crossborderbiotech.ca/2011/12/23/friday-science-review-december-23-2011/2011-12-22T20:47:16+00:00monthlyhttp://crossborderbiotech.ca/2011/12/16/friday-science-review-december-16-2011/2011-12-16T18:47:23+00:00monthlyhttp://crossborderbiotech.ca/2011/12/12/monday-biotech-deal-review-december-12-2011/2011-12-12T20:16:58+00:00monthlyhttp://crossborderbiotech.ca/2011/12/09/friday-science-review-december-9-2011/2011-12-08T17:27:22+00:00monthlyhttp://crossborderbiotech.ca/2011/12/05/monday-biotech-deal-review-december-5-2011/2011-12-05T19:41:03+00:00monthlyhttp://crossborderbiotech.ca/2011/11/28/monday-biotech-deal-review-november-28-2011/2011-11-28T16:35:22+00:00monthlyhttp://crossborderbiotech.ca/2011/11/25/friday-science-review-november-25-2011/2011-11-25T14:35:00+00:00monthlyhttp://crossborderbiotech.ca/2011/11/21/monday-biotech-deal-review-november-21-2011/2011-11-21T17:11:56+00:00monthlyhttp://crossborderbiotech.ca/2011/11/18/friday-science-review-november-18-2011/2011-11-17T22:36:58+00:00monthlyhttp://crossborderbiotech.ca/2011/11/14/monday-biotech-deal-review-november-14-2011/2011-11-14T15:43:44+00:00monthlyhttp://crossborderbiotech.ca/2011/11/11/friday-science-review-november-11-2011/2011-11-10T18:15:40+00:00monthlyhttp://crossborderbiotech.ca/2011/11/04/friday-science-review-november-4-2011/2011-11-03T21:01:46+00:00monthlyhttp://crossborderbiotech.ca/2011/10/21/friday-science-review-october-21-2011/2011-10-20T19:20:14+00:00monthlyhttp://crossborderbiotech.ca/2011/10/17/monday-biotech-deal-review-october-17-2011/2011-10-17T22:06:08+00:00monthlyhttp://crossborderbiotech.ca/2011/10/14/friday-science-review-october-14-2011/2011-10-13T21:09:04+00:00monthlyhttp://crossborderbiotech.ca/2011/10/12/assessing-potential-market-share-for-a-new-drug-part-14-of-valuation-and-other-biotech-mysteries/2011-12-10T04:09:15+00:00monthlyhttp://crossborderbiotech.ca/2011/10/11/potential-rewards-from-successful-drug-development-part-13-of-valuation-and-other-biotech-mysteries/2011-10-11T14:07:34+00:00monthlyhttp://crossborderbiotech.ca/2011/10/07/friday-science-review-october-7-2011/2011-10-05T17:59:48+00:00monthlyhttp://crossborderbiotech.ca/2011/10/03/monday-biotech-deal-review-october-3-2011/2011-10-03T14:45:05+00:00monthlyhttp://crossborderbiotech.ca/2011/09/30/friday-science-review-september-30-2011/2011-09-29T21:18:41+00:00monthlyhttp://crossborderbiotech.ca/2011/09/27/mixed-reaction-to-leahy-smith-america-invents-act/http://testbio.files.wordpress.com/2011/09/cv_150_150_franklin_andrew-38761.jpgcv_150_150_franklin_andrew-387612011-09-27T21:44:29+00:00monthlyhttp://crossborderbiotech.ca/2011/09/28/expansion-and-diversification-strategies-in-the-pharmaceutical-industry-part-12-of-valuation-and-other-biotech-mysteries/2011-09-27T21:37:21+00:00monthlyhttp://crossborderbiotech.ca/2011/09/26/monday-biotech-deal-review-september-26-2011/2011-09-27T00:36:32+00:00monthlyhttp://crossborderbiotech.ca/2011/09/23/friday-science-review-september-23-2011/2011-09-22T17:40:15+00:00monthlyhttp://crossborderbiotech.ca/2011/09/19/monday-biotech-deal-review-september-19-2011/2011-09-18T20:26:54+00:00monthlyhttp://crossborderbiotech.ca/2011/09/16/friday-science-review-september-16-2011/2011-09-16T13:40:17+00:00monthlyhttp://crossborderbiotech.ca/2011/09/12/monday-biotech-deal-review-september-12-2011/2011-09-12T22:20:56+00:00monthlyhttp://crossborderbiotech.ca/2011/09/09/friday-science-review-september-9-2011/2011-09-08T21:43:37+00:00monthlyhttp://crossborderbiotech.ca/2011/09/02/friday-science-review-september-2-2011/2011-09-02T13:17:44+00:00monthlyhttp://crossborderbiotech.ca/2011/08/29/monday-biotech-deal-review-august-29-2011/2011-08-29T03:22:58+00:00monthlyhttp://crossborderbiotech.ca/2011/08/24/canadian-healthcare-and-biotech-financings-q2-2011/2011-08-24T17:30:12+00:00monthlyhttp://crossborderbiotech.ca/2011/08/22/monday-biotech-deal-review-august-22-2011/2011-08-22T17:40:26+00:00monthlyhttp://crossborderbiotech.ca/2011/08/23/changes-in-pharmaceutical-industry-product-portfolios-and-strategies/2011-08-22T17:13:53+00:00monthlyhttp://crossborderbiotech.ca/2011/08/22/valuation-and-other-biotech-mysteries-%e2%80%93-part-10-some-pharmaceutical-industry-history/2011-08-22T16:52:11+00:00monthlyhttp://crossborderbiotech.ca/2011/08/19/friday-science-review-august-19-2011/2011-08-19T13:08:43+00:00monthlyhttp://crossborderbiotech.ca/2011/08/12/friday-science-review-august-12-2011/2011-08-12T03:50:29+00:00monthlyhttp://crossborderbiotech.ca/2011/08/08/monday-biotech-deal-review-august-8-2011/2011-08-08T17:21:23+00:00monthlyhttp://crossborderbiotech.ca/2011/08/05/friday-science-review-august-5-2011/2011-08-05T11:54:16+00:00monthlyhttp://crossborderbiotech.ca/2011/08/02/valuation-and-other-biotech-mysteries-%e2%80%93-part-9-retail-investors/2011-08-02T14:18:56+00:00monthlyhttp://crossborderbiotech.ca/2011/07/29/friday-science-review-july-29-2011/2011-07-29T15:05:26+00:00monthlyhttp://crossborderbiotech.ca/2011/07/25/monday-biotech-deal-review-july-25-2011/2011-07-25T16:47:23+00:00monthlyhttp://crossborderbiotech.ca/2011/07/22/friday-science-review-july-22-2011/2011-07-20T18:55:21+00:00monthlyhttp://crossborderbiotech.ca/2011/07/18/monday-biotech-deal-review/2011-07-18T19:13:55+00:00monthlyhttp://crossborderbiotech.ca/2011/07/15/friday-science-review-july-15-2011/http://testbio.files.wordpress.com/2011/07/mark-curtis-crop.jpgMark Curtis crop2011-07-18T04:42:05+00:00monthlyhttp://crossborderbiotech.ca/2011/07/08/friday-science-review-july-8-2011/http://testbio.files.wordpress.com/2011/07/mark-curtis.jpgMark Curtis2011-07-18T04:41:14+00:00monthlyhttp://crossborderbiotech.ca/2011/07/20/valuation-and-other-biotech-mysteries-%e2%80%93-part-8-the-current-state-of-healthcare-venture-capital/2011-07-18T04:34:24+00:00monthlyhttp://crossborderbiotech.ca/2011/07/19/valuation-and-other-biotech-mysteries-%e2%80%93-part-7-funding-the-cost-of-developing-a-new-drug-part-1/2011-07-18T04:31:04+00:00monthlyhttp://crossborderbiotech.ca/2011/07/11/monday-biotech-deal-review-july-11-2011/2011-07-11T04:11:35+00:00monthlyhttp://crossborderbiotech.ca/2011/07/07/valuation-and-other-biotech-mysteries-%e2%80%93-part-6-the-cost-of-developing-a-new-drug/2011-07-06T21:16:49+00:00monthlyhttp://crossborderbiotech.ca/2011/07/01/friday-science-review-july-1-2011/2011-06-30T17:27:14+00:00monthlyhttp://crossborderbiotech.ca/2011/06/27/monday-biotech-deal-review-june-27-2011/2011-06-27T11:44:39+00:00monthlyhttp://crossborderbiotech.ca/2011/06/24/friday-science-review-june-24-2011/2011-06-23T23:17:39+00:00monthlyhttp://crossborderbiotech.ca/2011/06/20/canadian-drug-pricing-and-reimbursement-conference-report/2011-06-20T14:58:26+00:00monthlyhttp://crossborderbiotech.ca/2011/06/20/monday-biotech-deal-review-june-20-2011/2011-06-20T14:21:36+00:00monthlyhttp://crossborderbiotech.ca/2011/06/21/valuation-and-other-biotech-mysteries-%e2%80%93-part-5-more-strategy-and-structure-for-phase-3-clinical-trials/2011-06-20T14:14:35+00:00monthlyhttp://crossborderbiotech.ca/2011/06/17/friday-science-review-june-17-2011/2011-06-16T19:25:00+00:00monthlyhttp://crossborderbiotech.ca/2011/06/16/preview-bio-and-scientific-americans-regional-bio-innovation-scorecard/2011-06-16T13:34:24+00:00monthlyhttp://crossborderbiotech.ca/2011/06/03/friday-science-review-june-3-2011/2011-06-15T13:54:10+00:00monthlyhttp://crossborderbiotech.ca/2011/06/13/monday-biotech-deal-review-june-13-2011/2011-06-13T11:58:12+00:00monthlyhttp://crossborderbiotech.ca/2011/06/10/friday-science-review-june-10-2011/2011-06-09T20:51:42+00:00monthlyhttp://crossborderbiotech.ca/2011/06/08/pharma-biotech-rd-budgets-%e2%80%93-a-proposal-for-measuring-performance/2011-06-17T17:16:36+00:00monthlyhttp://crossborderbiotech.ca/2011/06/06/monday-biotech-deal-review-june-6-2011/2011-06-07T16:19:24+00:00monthlyhttp://crossborderbiotech.ca/2011/06/06/biotech-valuation-part-4-strategy-and-structure-for-phase-3-clinical-trials/2011-06-13T03:21:46+00:00monthlyhttp://crossborderbiotech.ca/2011/06/01/biotech-valuation-part-3-what-are-you-valuing/2011-06-01T13:28:48+00:00monthlyhttp://crossborderbiotech.ca/2011/05/30/monday-biotech-deal-review-may-30-2011/2011-05-30T12:11:30+00:00monthlyhttp://crossborderbiotech.ca/2011/05/29/biotech-trends-update-%e2%80%94-ip-constituencies-innovator-generic-mixing-continues-in-canada/2011-05-29T00:27:28+00:00monthlyhttp://crossborderbiotech.ca/2011/05/27/friday-science-review-may-27-2011/2011-05-27T11:54:50+00:00monthlyhttp://crossborderbiotech.ca/2011/05/20/friday-science-review-may-20-2011/2011-05-20T11:48:29+00:00monthlyhttp://crossborderbiotech.ca/2011/05/18/valuation-and-other-biotech-mysteries-part-2-some-basic-mathematics/2011-05-18T19:59:15+00:00monthlyhttp://crossborderbiotech.ca/2011/05/16/monday-biotech-deal-review-may-16-2011/2011-05-15T23:50:25+00:00monthlyhttp://crossborderbiotech.ca/2011/05/13/friday-science-review-may-13-2011/2011-05-12T22:14:05+00:00monthlyhttp://crossborderbiotech.ca/2011/05/10/bio-world-congress-on-industrial-biotechnology-bioprocessing-day-1-review/2011-05-10T16:19:02+00:00monthlyhttp://crossborderbiotech.ca/2011/05/10/biotech-valuation-part-1/http://testbio.files.wordpress.com/2011/05/wayne-schnarr-serious.jpgWayne Schnarr – serious2011-05-10T13:38:34+00:00monthlyhttp://crossborderbiotech.ca/2011/05/09/bio-world-congress-on-industrial-biotechnology-bioprocessing/2011-05-09T21:21:39+00:00monthlyhttp://crossborderbiotech.ca/2011/05/09/monday-biotech-deal-review-may-9-2011/2011-05-09T04:23:37+00:00monthlyhttp://crossborderbiotech.ca/2011/05/06/friday-science-review-may-6-2011/2011-05-05T19:03:56+00:00monthlyhttp://crossborderbiotech.ca/2011/05/02/monday-biotech-deal-review-may-2-2011/2011-05-02T05:07:32+00:00monthlyhttp://crossborderbiotech.ca/2011/04/29/friday-science-review-april-29-2011/2011-04-29T04:36:35+00:00monthlyhttp://crossborderbiotech.ca/2011/04/27/q1-2011-canadian-biotech-healthcare-review-some-financing-carry-over-from-the-strong-q4-2010/2011-04-26T21:25:19+00:00monthlyhttp://crossborderbiotech.ca/2011/04/22/friday-science-review-april-22-2011/2011-04-22T15:16:55+00:00monthlyhttp://crossborderbiotech.ca/2011/04/18/monday-biotech-deal-review-april-18-2011/2011-04-18T02:18:04+00:00monthlyhttp://crossborderbiotech.ca/2011/04/15/friday-science-review-april-15-2011/2011-04-15T11:22:24+00:00monthlyhttp://crossborderbiotech.ca/2011/04/11/monday-biotech-deal-review-april-11-2011/2011-04-10T23:34:50+00:00monthlyhttp://crossborderbiotech.ca/2011/04/08/friday-science-review-april-7-2011/2011-04-08T11:46:15+00:00monthlyhttp://crossborderbiotech.ca/2011/04/04/monday-biotech-deal-review-april-4-2011/2011-04-05T20:05:47+00:00monthlyhttp://crossborderbiotech.ca/2011/04/05/myriad-genetics-v-aclu-in-the-federal-circuit/http://testbio.files.wordpress.com/2011/04/myriad-aclu.jpgmyriad-aclu2011-04-05T20:01:12+00:00monthlyhttp://crossborderbiotech.ca/2011/03/29/flow-through-shares-for-biotech-part-2-of-3-flow-throughs-in-mining-and-oil-gas/2011-04-05T13:52:48+00:00monthlyhttp://crossborderbiotech.ca/2011/04/05/flow-through-shares-for-biotech-part-3-of-3-what-if-it-actually-happens/2011-04-05T13:51:56+00:00monthlyhttp://crossborderbiotech.ca/2011/04/01/friday-science-review-april-1st-2011/2011-04-01T10:56:24+00:00monthlyhttp://crossborderbiotech.ca/2011/03/24/flow-through-shares-for-healthcare-part-1-of-3-what-are-flow-through-shares/2011-03-28T21:41:13+00:00monthlyhttp://crossborderbiotech.ca/2011/03/28/monday-biotech-deal-review-march-29-2011/2011-03-28T04:14:08+00:00monthlyhttp://crossborderbiotech.ca/2011/03/25/friday-science-review-march-25-2011/2011-03-24T19:09:52+00:00monthlyhttp://crossborderbiotech.ca/2011/03/21/monday-biotech-deal-review-march-21-2011/2011-03-21T04:14:02+00:00monthlyhttp://crossborderbiotech.ca/2011/03/18/friday-science-review-march-18-2011/2011-03-17T20:16:00+00:00monthlyhttp://crossborderbiotech.ca/2011/03/14/monday-biotech-deal-review-march-14-2011/2011-03-13T22:57:29+00:00monthlyhttp://crossborderbiotech.ca/2011/03/11/friday-science-review-march-11-2011/2011-03-11T16:27:33+00:00monthlyhttp://crossborderbiotech.ca/2011/03/07/monday-biotech-deal-review-march-7-2011/2011-03-08T17:17:51+00:00monthlyhttp://crossborderbiotech.ca/2011/03/08/stability-at-the-top-a-look-at-top-biotech-venture-capital-deals-from-2007-2010/http://testbio.files.wordpress.com/2011/02/vc-investment-normalized-2007-2010.jpgVC Investment – normalized 2007-20102011-03-07T11:39:20+00:00monthlyhttp://crossborderbiotech.ca/2011/03/04/friday-science-review-march-4-2011/2011-03-04T12:29:36+00:00monthlyhttp://crossborderbiotech.ca/2011/02/28/monday-biotech-deal-review-february-28-2011/2011-02-28T08:44:03+00:00monthlyhttp://crossborderbiotech.ca/2011/02/25/friday-science-review-february-25-2011/2011-02-25T16:41:25+00:00monthlyhttp://crossborderbiotech.ca/2011/02/21/monday-biotech-deal-review-february-21-2011/2011-02-21T01:05:20+00:00monthlyhttp://crossborderbiotech.ca/2011/02/18/friday-science-review-february-18-2011/2011-02-18T13:05:28+00:00monthlyhttp://crossborderbiotech.ca/2011/02/14/monday-biotech-deal-review-february-14-2011/2011-02-14T06:34:16+00:00monthlyhttp://crossborderbiotech.ca/2011/02/11/friday-science-review-february-11-2011/2011-02-10T22:08:14+00:00monthlyhttp://crossborderbiotech.ca/2011/02/10/2010-canada-biotech-canada-healthcare-review-success-and-momentum-building/2011-02-10T15:03:14+00:00monthlyhttp://crossborderbiotech.ca/2011/02/04/friday-science-review-february-4-2011/2011-09-22T10:12:51+00:00monthlyhttp://crossborderbiotech.ca/2011/02/07/monday-biotech-deal-review-february-7-2011/2011-02-07T06:48:43+00:00monthlyhttp://crossborderbiotech.ca/2011/01/28/friday-science-review-january-28-2011/2011-02-01T15:12:36+00:00monthlyhttp://crossborderbiotech.ca/2011/01/31/monday-biotech-deal-review-january-31-2011/2011-01-31T05:50:18+00:00monthlyhttp://crossborderbiotech.ca/2010/10/27/ten-corporate-law-tips-for-startups-in-canada/2011-01-27T01:03:37+00:00monthlyhttp://crossborderbiotech.ca/2011/01/25/the-real-end-of-evolution-natural-selection-makes-itself-extinct-through-genomics-and-pre-implantation-screening/http://testbio.files.wordpress.com/2011/01/embryo_8_cells.jpgEmbryo,_8_cells2011-01-24T21:06:52+00:00monthlyhttp://crossborderbiotech.ca/2011/01/21/friday-science-review-january-21-2011/2011-01-24T18:45:27+00:00monthlyhttp://crossborderbiotech.ca/2011/01/24/monday-biotech-deal-review-january-24-2010/2011-01-24T04:33:43+00:00monthlyhttp://crossborderbiotech.ca/2011/01/19/biotech-trends-in-2011-biosimilars-follow-on-biologics-subsequent-entry-biologics/2011-01-19T05:28:26+00:00monthlyhttp://crossborderbiotech.ca/2011/01/17/monday-biotech-deal-review-january-17-2011/2011-01-17T04:17:17+00:00monthlyhttp://crossborderbiotech.ca/2011/01/14/friday-science-review-january-14-2011/2011-01-17T02:56:56+00:00monthlyhttp://crossborderbiotech.ca/2011/01/15/weekend-reading-this-week-in-the-biotech-twitter-verse-2/2011-01-15T19:48:08+00:00monthlyhttp://crossborderbiotech.ca/2011/01/13/biotech-trends-in-2011-transgenic-crops-transgenic-animals/2011-01-13T14:59:15+00:00monthlyhttp://crossborderbiotech.ca/2011/01/10/canada-biotech-financings-review-2010/2011-01-10T16:10:34+00:00monthlyhttp://crossborderbiotech.ca/2011/01/10/monday-biotech-deal-review-january-10-2011/2011-01-10T09:14:17+00:00monthlyhttp://crossborderbiotech.ca/2011/01/11/biotech-trends-in-2011-commercialization-by-nonprofit-foundations/http://testbio.files.wordpress.com/2011/01/cfti-logo.jpgCFTI Logo2011-01-10T09:02:27+00:00monthlyhttp://crossborderbiotech.ca/trends-in-2009/commercialization-by-non-profit-foundations/2011-01-10T05:32:20+00:00weekly0.6http://crossborderbiotech.ca/2011/01/07/friday-science-review-january-7-2011/2011-01-08T14:37:06+00:00monthlyhttp://crossborderbiotech.ca/2011/01/08/weekend-reading-this-week-in-the-twitterverse/2011-01-08T13:04:30+00:00monthlyhttp://crossborderbiotech.ca/2010/01/07/trends-update-personalized-medicine-a-big-market-if-we-can-just-figure-out-how-to-get-people-to-use-it/2011-01-05T04:38:26+00:00monthlyhttp://crossborderbiotech.ca/2011/01/04/biotech-trends-in-2011-comparative-effectiveness-and-personalized-medicine/http://testbio.files.wordpress.com/2011/01/bw-dna_sequence.jpgB&W DNA_sequence2011-01-04T19:47:00+00:00monthlyhttp://crossborderbiotech.ca/2011/01/04/biotech-trends-in-2011-social-media-in-biotech-and-healthcare/2011-01-04T19:29:17+00:00monthlyhttp://crossborderbiotech.ca/2009/02/10/personalized-medicine-first-saec-data/2011-01-04T18:48:01+00:00monthlyhttp://crossborderbiotech.ca/trends-in-2009/comparative-effectiveness-and-personalized-medicine/2011-01-04T16:58:59+00:00weekly0.6http://crossborderbiotech.ca/2011/01/03/monday-biotech-deal-review-january-3-2011/2011-01-03T04:28:55+00:00monthlyhttp://crossborderbiotech.ca/2010/12/31/friday-science-review-december-31-2010/2010-12-30T15:12:03+00:00monthlyhttp://crossborderbiotech.ca/2010/12/27/monday-biotech-happy-holidays-deal-review-december-27-2010/2010-12-27T05:18:21+00:00monthlyhttp://crossborderbiotech.ca/2010/12/24/friday-science-review-december-24-2010/http://testbio.files.wordpress.com/2010/12/468891a-i1-0.jpg468891a-i1.02010-12-22T17:25:42+00:00monthlyhttp://crossborderbiotech.ca/2010/12/18/weekend-reading-this-week-in-the-biotech-twitter-verse/2010-12-19T18:40:25+00:00monthlyhttp://crossborderbiotech.ca/2010/12/17/friday-science-review-december-17-2010/2010-12-16T20:37:39+00:00monthlyhttp://crossborderbiotech.ca/2010/12/16/trends-update-social-media-reshaping-healthcare-twitter-as-a-public-health-surveillance-tool-for-the-21st-century/2010-12-16T19:44:01+00:00monthlyhttp://crossborderbiotech.ca/2010/12/13/monday-biotech-deal-review-december-13-2010/2010-12-13T09:02:13+00:00monthlyhttp://crossborderbiotech.ca/2010/12/11/this-week-in-the-biotech-twitter-verse-23-6/2010-12-12T14:27:17+00:00monthlyhttp://crossborderbiotech.ca/2010/12/10/friday-science-review-december-10-2010/2010-12-10T00:14:44+00:00monthlyhttp://crossborderbiotech.ca/trends-in-2009/shifting-ip-constituencies/2010-12-07T16:36:03+00:00weekly0.6http://crossborderbiotech.ca/2010/12/07/biotech-trends-update-ip-constituencies-indian-industry-lobbies-to-keep-ip-out-of-free-trade-agreement-with-eu/2010-12-07T16:32:30+00:00monthlyhttp://crossborderbiotech.ca/2010/12/06/monday-biotech-deal-review-december-6-2010/2010-12-06T06:37:50+00:00monthlyhttp://crossborderbiotech.ca/2010/12/04/this-week-in-the-biotech-twitter-verse-23-5/2010-12-05T00:23:57+00:00monthlyhttp://crossborderbiotech.ca/2010/12/03/friday-science-review-december-3-2010/2010-12-03T11:23:10+00:00monthlyhttp://crossborderbiotech.ca/2010/12/02/canadian-biotech-and-healthcare-licensing-trends-in-2010/2010-12-03T05:34:19+00:00monthlyhttp://crossborderbiotech.ca/2010/11/29/monday-biotech-deal-review-november-29-2010/2010-11-29T06:37:30+00:00monthlyhttp://crossborderbiotech.ca/2010/11/27/this-week-in-the-biotech-twitter-verse-23-4/2010-11-27T16:40:03+00:00monthlyhttp://crossborderbiotech.ca/2010/11/26/friday-science-review-november-26-2010/2010-11-25T19:00:28+00:00monthlyhttp://crossborderbiotech.ca/2010/11/24/regenerative-medicine-takes-off-en-route-to-reality/2010-11-24T21:44:47+00:00monthlyhttp://crossborderbiotech.ca/2010/11/23/uk-invests-200m-in-technology-innovation-centres-goes-with-fraunhofer%c2%a0model/2011-07-04T19:24:05+00:00monthlyhttp://crossborderbiotech.ca/2010/11/22/monday-biotech-deal-review-november-22-2010/2010-11-22T14:13:36+00:00monthlyhttp://crossborderbiotech.ca/2010/11/20/this-week-in-the-biotech-twitterverse-23/2010-11-20T19:20:43+00:00monthlyhttp://crossborderbiotech.ca/2010/11/19/friday-science-review-november-19-2010/2010-11-18T22:54:14+00:00monthlyhttp://crossborderbiotech.ca/2010/11/16/biotech-in-the-provinces-obest-gears-up-for-regional-meetings-western-canada-innovation-agreement-to-provide-seed-funding/2010-11-17T21:55:53+00:00monthlyhttp://crossborderbiotech.ca/2010/11/13/this-week-in-the-biotech-twitter-verse-23-3/2010-11-16T17:04:28+00:00monthlyhttp://crossborderbiotech.ca/2010/11/15/new-firm-new-contributors-contribute-to-new%c2%a0look/2010-11-16T01:14:40+00:00monthlyhttp://crossborderbiotech.ca/2010/11/15/monday-deal-review-november-15-2010/2010-11-15T14:19:56+00:00monthlyhttp://crossborderbiotech.ca/2010/11/12/friday-science-review-november-12-2010/2010-11-12T12:29:27+00:00monthlyhttp://crossborderbiotech.ca/trends-in-2009/follow-on-biologics-aka-biosimilars-subsequent-entry-biologics/2010-11-10T17:30:49+00:00weekly0.6http://crossborderbiotech.ca/2010/11/10/fda-biosimilars-hearing-issues/2010-11-10T17:28:44+00:00monthlyhttp://crossborderbiotech.ca/2010/11/08/stem-cell-breakthrough-direct-conversion-of-human-skin-to-blood/2010-11-09T12:11:53+00:00monthlyhttp://crossborderbiotech.ca/2010/11/08/monday-deal-review-november-8-2010/2010-11-08T12:55:54+00:00monthlyhttp://crossborderbiotech.ca/2010/11/06/this-week-in-the-biotech-twitter-verse-23-2/2010-11-06T21:51:07+00:00monthlyhttp://crossborderbiotech.ca/2010/11/05/friday-science-review-november-5-2010/2010-11-05T15:02:13+00:00monthlyhttp://crossborderbiotech.ca/2010/11/04/u-s-therapeutic-discovery-stimulus-reaches-biotechs-in-canada-israel-germany/2010-11-04T22:31:53+00:00monthlyhttp://crossborderbiotech.ca/2010/11/02/q3-canadian-biotech-review-%e2%80%93-weakness-continues-but-some-bright-spots/2010-11-01T23:13:23+00:00monthlyhttp://crossborderbiotech.ca/2010/11/01/monday-deal-review-november-1-2010/2010-11-01T13:58:15+00:00monthlyhttp://crossborderbiotech.ca/2010/10/31/this-week-in-the-biotech-twitter-verse-23/2010-10-31T05:57:41+00:00monthlyhttp://crossborderbiotech.ca/2010/10/29/friday-science-review-october-29-2010/2010-10-29T15:47:31+00:00monthlyhttp://crossborderbiotech.ca/2010/10/28/technology-transfer-at-canadian-universities/2010-10-28T14:03:53+00:00monthlyhttp://crossborderbiotech.ca/2010/10/26/two-mars-innovation-transactions-take-off/2010-10-26T15:36:23+00:00monthlyhttp://crossborderbiotech.ca/2010/10/25/monday-biotech-deal-review-october-25-2010/2010-10-25T03:18:25+00:00monthlyhttp://crossborderbiotech.ca/2010/10/23/this-week-in-the-twitterverse-22/2010-10-23T22:15:42+00:00monthlyhttp://crossborderbiotech.ca/2010/10/22/friday-science-review-october-22-2010/http://testbio.files.wordpress.com/2010/10/helix.jpghelix2010-10-22T11:27:34+00:00monthlyhttp://crossborderbiotech.ca/2010/10/21/biotech-trends-update-biosimilars-blur-ip-constituencies-novartis-and-pfizer-biocon-are-featured-in-the-economist/2010-10-22T03:33:02+00:00monthlyhttp://crossborderbiotech.ca/2010/10/18/monday-deal-review-october-18-2010/2010-10-18T07:37:57+00:00monthlyhttp://crossborderbiotech.ca/2010/10/16/this-week-in-the-biotech-twitter-verse-4/2010-10-17T00:55:53+00:00monthlyhttp://crossborderbiotech.ca/2010/10/01/friday-science-review-october-1-2010/2010-10-15T17:55:35+00:00monthlyhttp://crossborderbiotech.ca/2010/10/15/friday-science-review-october-15-2010/2010-10-15T12:48:46+00:00monthlyhttp://crossborderbiotech.ca/2010/10/14/biotech-trends-update-personalized-medicine-duncans-personalized-health-manifesto-is-primarily-preventative/http://testbio.files.wordpress.com/2010/10/soapbox.jpgSoapbox2010-10-14T16:02:13+00:00monthlyhttp://crossborderbiotech.ca/2010/10/11/monday-biotech-deal-review-october-11-2010/2010-10-11T05:37:31+00:00monthlyhttp://crossborderbiotech.ca/2010/10/08/friday-science-review-october-8-2010/2010-10-12T01:12:56+00:00monthlyhttp://crossborderbiotech.ca/2010/10/05/biotech-trends-update-biosimilars-fda-meeting-formally-announced-ema-working-on-rules-for-a-few-antibody-biosimilars/http://testbio.files.wordpress.com/2010/10/ema_logo_banner1.jpgEMA_Logo_banner2010-10-05T18:05:34+00:00monthlyhttp://crossborderbiotech.ca/2010/10/04/canadian-venture-capital-data-from-q2-2010-shows-big-jump-from-q2-2009-but-only-moderate-increase-for-biotech/2010-10-04T17:32:26+00:00monthlyhttp://crossborderbiotech.ca/2010/10/04/monday-biotech-deal-review-october-4-2010/2010-10-04T02:17:29+00:00monthlyhttp://crossborderbiotech.ca/2010/10/02/this-week-in-the-biotech-twitter-verse-3/2010-10-02T17:21:55+00:00monthlyhttp://crossborderbiotech.ca/2010/09/29/more-oetf-investments-announced-including-neuraxon/2010-09-29T16:54:54+00:00monthlyhttp://crossborderbiotech.ca/2010/09/25/this-week-in-the-biotech-twitter-verse-2/2010-09-29T00:38:23+00:00monthlyhttp://crossborderbiotech.ca/2010/09/29/biotech-trends-update-ip-constituencies-endos-qualitest-purchase-shows-full-integration-of-innovator-and-generic-strategies/2010-09-29T13:41:58+00:00monthlyhttp://crossborderbiotech.ca/2010/09/27/monday-biotech-deal-review-september-27-2010/2010-09-27T00:40:11+00:00monthlyhttp://crossborderbiotech.ca/2010/09/24/cross-border-biotech-blog-news-favourite-features-returning-with-new-authors/2010-09-24T15:56:14+00:00monthlyhttp://crossborderbiotech.ca/2010/09/22/why-technology-transfer-offices-should-focus-on-sponsored-research-and-ignore-royalties-in-praise-of-uncs-express-license/2010-09-23T23:17:54+00:00monthlyhttp://crossborderbiotech.ca/2010/09/20/biotech-trends-update-biosimilars-fda-meeting-in-november-to-discuss-bcpi-act-implementation/2010-10-07T12:24:07+00:00monthlyhttp://crossborderbiotech.ca/2010/09/15/flow-through-shares-for-biotech-welcome-to-national-biotechnology-week-in-canada/http://testbio.files.wordpress.com/2010/09/nbw_web_eng.jpgNBW_web_eng2010-11-24T16:53:23+00:00monthlyhttp://crossborderbiotech.ca/2010/09/14/agricultural-biotechnology-international-conference-abic-canada-white-biotech/http://testbio.files.wordpress.com/2010/09/abic2010-square70px.jpgABIC2010-square70px2010-09-14T18:16:07+00:00monthlyhttp://crossborderbiotech.ca/2010/08/22/gone-fishing/2010-09-07T13:38:34+00:00monthlyhttp://crossborderbiotech.ca/2010/08/16/monday-biotech-deal-review-august-16-2010-2/2010-08-16T03:53:49+00:00monthlyhttp://crossborderbiotech.ca/2010/08/14/this-week-in-the-twitterverse-21/2010-08-14T17:05:40+00:00monthlyhttp://crossborderbiotech.ca/2010/08/09/ontario-emerging-technologies-fund-oetf-shows-signs-of-life-sciences-adds-biotech-investments-and-investors/2010-08-09T21:32:47+00:00monthlyhttp://crossborderbiotech.ca/2010/08/09/monday-biotech-deal-review-august-9-2010/2010-08-09T19:27:34+00:00monthlyhttp://crossborderbiotech.ca/about/google0fb0a9700fc3bce1-html/2010-08-08T20:21:54+00:00weekly0.6http://crossborderbiotech.ca/2010/08/07/this-week-in-the-biotech-twitter-verse-21-3/2010-08-08T00:25:21+00:00monthlyhttp://crossborderbiotech.ca/2010/07/29/feddev-ontario-is-feeding-45-million-through-nrc-irap-to-support-smb-innovation/2010-07-30T02:36:48+00:00monthlyhttp://crossborderbiotech.ca/2010/07/26/monday-biotech-deal-review-july-26-2010/2010-07-26T10:41:13+00:00monthlyhttp://crossborderbiotech.ca/2010/07/24/this-week-in-the-biotech-twitter-verse-21-2/2010-07-24T14:00:14+00:00monthlyhttp://crossborderbiotech.ca/2010/07/20/q2-canadian-healthcare-review-shows-biotech-financing-weakness-but-some-ma-and-regulatory-wins/2010-07-20T19:53:26+00:00monthlyhttp://crossborderbiotech.ca/2010/07/19/monday-biotech-deal-review-july-19-2010/2010-07-19T08:21:48+00:00monthlyhttp://crossborderbiotech.ca/2010/07/17/this-week-in-the-biotech-twitter-verse-21/2010-07-17T03:17:23+00:00monthlyhttp://crossborderbiotech.ca/2010/07/14/ey-beyond-borders-biotech-report-2010-canadian-biotech-data/2010-07-15T13:58:32+00:00monthlyhttp://crossborderbiotech.ca/2010/07/12/monday-biotech-deal-review-july-12-2010/2010-07-12T14:27:28+00:00monthlyhttp://crossborderbiotech.ca/2010/07/10/this-week-in-the-twitterverse-20/2010-07-10T20:38:28+00:00monthlyhttp://crossborderbiotech.ca/2010/07/05/monday-biotech-deal-review-july-5-2010/2010-07-05T03:20:30+00:00monthlyhttp://crossborderbiotech.ca/2010/07/03/this-week-in-the-twitterverse-19/2010-07-03T21:46:13+00:00monthlyhttp://crossborderbiotech.ca/2010/06/28/key-quotes-from-the-u-s-supreme-courts-decision-in-bilski-shows-no-current-impact-on-biotech/2010-06-28T16:51:16+00:00monthlyhttp://crossborderbiotech.ca/2010/06/28/monday-biotech-deal-review-june-28-2010/2010-06-28T15:46:59+00:00monthlyhttp://crossborderbiotech.ca/2010/06/27/this-week-in-the-biotech-twitter-verse-19-2/2010-06-27T19:57:05+00:00monthlyhttp://crossborderbiotech.ca/2010/06/21/monday-biotech-deal-review-june-21-2010/2010-06-21T04:21:28+00:00monthlyhttp://crossborderbiotech.ca/2010/06/19/this-week-in-the-biotech-twitter-verse-19/2010-06-19T17:08:51+00:00monthlyhttp://crossborderbiotech.ca/2010/06/18/health-canadas-pharmacovigilance-program-provides-consumers-with-consumer-unfriendly-form-for-direct-reporting-of-adverse-effects/http://testbio.files.wordpress.com/2010/06/medeffect-banner.jpgMedEffect Banner2010-06-18T15:07:48+00:00monthlyhttp://crossborderbiotech.ca/2010/06/14/monday-biotech-deal-review-june-14-2010/2010-06-14T15:46:30+00:00monthlyhttp://crossborderbiotech.ca/2010/06/07/monday-biotech-deal-review-june-7-2010/2010-06-14T15:39:56+00:00monthlyhttp://crossborderbiotech.ca/2010/06/12/this-week-in-the-twitterverse-18/2010-06-12T16:22:12+00:00monthlyhttp://crossborderbiotech.ca/2010/06/11/friday-science-review-june-11-2010/2010-06-11T15:00:58+00:00monthlyhttp://crossborderbiotech.ca/2010/06/07/biotechs-murky-ipo-window-increases-ma-attractiveness/2010-06-07T20:48:44+00:00monthlyhttp://crossborderbiotech.ca/2010/06/06/this-week-in-the-twitterverse-17/2010-06-06T14:53:14+00:00monthlyhttp://crossborderbiotech.ca/2010/06/04/friday-science-review-june-4-2010/2010-06-04T14:58:04+00:00monthlyhttp://crossborderbiotech.ca/2010/06/03/biotech-ipos-past-10-years-after-the-biotech-venture-capital-boom-of-1999-2001/2010-06-03T16:18:58+00:00monthlyhttp://crossborderbiotech.ca/2010/06/03/welcome-to-new-cross-border-biotech-blog-contributor-wayne-schnarr/2010-06-03T16:18:09+00:00monthlyhttp://crossborderbiotech.ca/2010/05/31/monday-biotech-deal-review-may-31-2010/2010-06-01T02:17:31+00:00monthlyhttp://crossborderbiotech.ca/2010/05/30/this-week-in-the-twitterverse-16/2010-05-30T08:18:45+00:00monthlyhttp://crossborderbiotech.ca/2010/05/28/friday-science-review-may-28-2010/2010-05-28T16:40:32+00:00monthlyhttp://crossborderbiotech.ca/2010/05/25/patent-cliff-will-not-save-biotech-abbott-buys-indian-generics-company-piramal-healthcare/http://testbio.files.wordpress.com/2010/05/patent-cliff.jpgpatent cliff2010-05-25T15:00:44+00:00monthlyhttp://crossborderbiotech.ca/2010/05/21/friday-science-review-may-21-2010/http://testbio.files.wordpress.com/2010/05/nbt0510-407-f3.gifnbt0510-407-F3South-South Collaboration Network of Health Biotech Firms2010-05-24T02:14:10+00:00monthlyhttp://crossborderbiotech.ca/2010/05/20/trends-update-synthetic-biology-jcvis-first-synthetic-cell-or-a-goat-walked-into-a-lab/2010-05-24T02:14:03+00:00monthlyhttp://crossborderbiotech.ca/2010/05/24/monday-biotech-deal-review-may-24-2010/2010-05-24T01:24:38+00:00monthlyhttp://crossborderbiotech.ca/2010/05/22/this-week-in-the-biotech-twitterverse-16/2010-05-22T23:00:22+00:00monthlyhttp://crossborderbiotech.ca/2010/05/17/monday-biotech-deal-review-may-17-2010/2010-05-18T06:33:32+00:00monthlyhttp://crossborderbiotech.ca/2010/05/15/this-week-in-the-biotech-twitter-verse-16-2/2010-05-15T23:59:27+00:00monthlyhttp://crossborderbiotech.ca/2010/05/14/friday-science-review-may-14-2010/2010-05-14T16:18:36+00:00monthlyhttp://crossborderbiotech.ca/2010/05/11/grand-challenges-canada-to-mobilize-225-million-over-5-years-for-global-health/http://testbio.files.wordpress.com/2010/05/grand-challenges-canada-jpeg-logo.jpgGrand Challenges Canada JPEG Logo2010-05-11T01:36:24+00:00monthlyhttp://crossborderbiotech.ca/2010/05/10/monday-biotech-deal-review-may-10-2010/2010-05-10T04:09:09+00:00monthlyhttp://crossborderbiotech.ca/2010/05/08/this-week-in-the-biotech-twitter-verse-16/2010-05-08T18:31:58+00:00monthlyhttp://crossborderbiotech.ca/2010/05/07/friday-science-review-may-7-2010/2010-05-07T15:23:42+00:00monthlyhttp://crossborderbiotech.ca/2010/05/06/bio-2010-summarized-in-song/2010-05-06T17:38:02+00:00monthlyhttp://crossborderbiotech.ca/2010/05/04/bio-panel-on-comparative-effectiveness-research-notes-silver-lining-of-personalized-medicine/2010-05-04T16:13:38+00:00monthlyhttp://crossborderbiotech.ca/2010/05/03/biotech-trends-update-non-dilutive-financing-and-fundraising-by-partnering-with-nonprofits/2010-05-03T21:16:39+00:00monthlyhttp://crossborderbiotech.ca/2010/05/03/battelle-bio-data-on-biotech-investment-and-jobs/2010-05-03T17:03:42+00:00monthlyhttp://crossborderbiotech.ca/2010/05/03/monday-biotech-deal-review-may-3-2010/2010-05-03T03:36:31+00:00monthlyhttp://crossborderbiotech.ca/2010/05/02/pubmed-central-canada-opens-for-business-free-online-access-to-life-sciences-journals/http://testbio.files.wordpress.com/2010/05/pubmed-central-canada-logo.gifPubMed Central Canada Logo2010-05-02T19:07:13+00:00monthlyhttp://crossborderbiotech.ca/2010/05/01/this-week-in-the-twitterverse-15/2010-05-01T20:49:13+00:00monthlyhttp://crossborderbiotech.ca/2010/04/30/ontarios-new-life-sciences-strategy-announced-by-minister-of-research-and-innovation-john-milloy/2010-04-30T17:53:51+00:00monthlyhttp://crossborderbiotech.ca/2010/04/30/friday-science-review-april-30-2010/2010-04-30T15:04:58+00:00monthlyhttp://crossborderbiotech.ca/2010/04/28/biotech-trends-at-bio-2010/2010-04-28T16:13:25+00:00monthlyhttp://crossborderbiotech.ca/2010/04/26/monday-biotech-deal-review-april-26-2010/2010-04-26T03:27:19+00:00monthlyhttp://crossborderbiotech.ca/2010/04/24/this-week-in-the-biotech-twitterverse-15/2010-04-24T18:25:29+00:00monthlyhttp://crossborderbiotech.ca/2010/04/23/friday-science-review-april-23-2010/2010-04-23T17:11:31+00:00monthlyhttp://crossborderbiotech.ca/2010/04/23/canadian-flax-growers-plan-a-roundup-resistant-strain-that-may-also-resist-eus-gm-resistance-in-new-5-5m-collaboration-with-cibus-global/http://testbio.files.wordpress.com/2010/04/flax-capacitor.jpgflax capacitor2010-04-23T15:52:55+00:00monthlyhttp://crossborderbiotech.ca/2010/04/21/health-canadas-statistics-on-patent-listings-and-generics-litigation/2010-04-22T03:19:31+00:00monthlyhttp://crossborderbiotech.ca/2010/04/19/monday-biotech-deal-review-april-19-2010/2010-04-20T03:18:33+00:00monthlyhttp://crossborderbiotech.ca/2010/04/17/this-week-in-the-biotech-twitter/2010-04-17T19:32:34+00:00monthlyhttp://crossborderbiotech.ca/2010/04/15/biotech-trends-update-social-media-for-biotechs-building-momentum-toward-critical-mass/2010-04-16T15:41:29+00:00monthlyhttp://crossborderbiotech.ca/2010/04/19/biotech-trends-update-commercialization-by-foundations-lymphoma-and-leukaemia-societys-preclinical-program/2010-04-16T15:41:15+00:00monthlyhttp://crossborderbiotech.ca/2010/04/16/friday-science-review-april-16-2010/2010-04-16T15:26:41+00:00monthlyhttp://crossborderbiotech.ca/2010/04/12/monday-biotech-deal-review-april-12-2010/2010-04-12T06:23:42+00:00monthlyhttp://crossborderbiotech.ca/2010/04/11/2010-gairdner-award-winners-announced/2010-04-11T04:04:53+00:00monthlyhttp://crossborderbiotech.ca/2010/04/10/this-week-in-the-biotech-twitter-verse/2010-04-10T13:58:52+00:00monthlyhttp://crossborderbiotech.ca/2010/04/09/friday-science-review-april-9-2010/2010-04-09T15:42:28+00:00monthlyhttp://crossborderbiotech.ca/2010/04/06/state-of-the-biotech-industry-heading-into-biofinance/2010-04-06T16:53:18+00:00monthlyhttp://crossborderbiotech.ca/2010/04/06/comparative-effectiveness-and-personalized-medicine-are-part-of-the-same-question-collins-confirms/2010-04-06T16:52:46+00:00monthlyhttp://crossborderbiotech.ca/2010/04/05/monday-biotech-deal-review-april-5-2010/2010-04-05T03:29:52+00:00monthlyhttp://crossborderbiotech.ca/2010/04/04/this-week-in-the-biotech-twitterverse-5/2010-04-04T14:15:35+00:00monthlyhttp://crossborderbiotech.ca/2010/04/01/top-5-reasons-the-myriad-genetics-alcu-patent-ruling-is-not-a-big-deal/2010-04-01T04:29:31+00:00monthlyhttp://crossborderbiotech.ca/2010/03/29/monday-biotech-deal-review-march-29-2010/2010-03-28T23:59:39+00:00monthlyhttp://crossborderbiotech.ca/2010/03/27/this-week-in-the-twitterverse-14/2010-03-28T23:33:37+00:00monthlyhttp://crossborderbiotech.ca/2010/03/26/friday-science-review-march-26-2010/2010-03-28T23:33:10+00:00monthlyhttp://crossborderbiotech.ca/2010/03/25/ontario-budget-2010-reserving-final-judgment/2010-03-28T23:33:05+00:00monthlyhttp://crossborderbiotech.ca/2010/03/25/ontario-budget-2010-stands-still-on-innovation/2010-03-26T14:15:48+00:00monthlyhttp://crossborderbiotech.ca/2010/03/24/capstone-therapeutics-proposed-put-rights-put-the-companys-future-in-investors-hands-heres-how-they-work-and-why/2010-03-25T01:07:57+00:00monthlyhttp://crossborderbiotech.ca/2010/03/24/biotech-trends-update-chemgenex-shows-the-importance-of-companion-diagnostic-development/2010-03-24T04:40:55+00:00monthlyhttp://crossborderbiotech.ca/2010/03/12/friday-science-review-march-12-2010/2010-03-23T02:20:04+00:00monthlyhttp://crossborderbiotech.ca/2010/03/22/monday-biotech-companie-review-march-22-2010/2010-03-23T02:10:44+00:00monthlyhttp://crossborderbiotech.ca/2010/03/22/health-canada-calibrates-caffeine-consumption-energy-drinks-may-get-new-labels/http://testbio.files.wordpress.com/2010/03/battery_energy_drink.jpgBattery_energy_drink2010-03-22T02:10:03+00:00monthlyhttp://crossborderbiotech.ca/2010/03/20/this-week-in-the-biotech-twitterverse-4/2010-03-20T23:27:42+00:00monthlyhttp://crossborderbiotech.ca/2010/03/19/friday-science-review-march-19-2010/2010-03-19T14:19:18+00:00monthlyhttp://crossborderbiotech.ca/2010/03/18/biotech-trends-update-a-personalized-critique-of-comparative-effectiveness-misses-the-mark/2011-05-12T15:19:51+00:00monthlyhttp://crossborderbiotech.ca/bailout/2010-03-17T04:58:02+00:00weekly0.6http://crossborderbiotech.ca/2010/03/16/subsequent-entry-biologics-aka-biosimilars-get-final-health-canada-guidance-6-years-of-data-exclusivity/2010-10-09T07:04:25+00:00monthlyhttp://crossborderbiotech.ca/2010/03/15/deal-review-is-on-vacation/2010-03-15T05:41:55+00:00monthlyhttp://crossborderbiotech.ca/2010/03/13/this-week-in-the-biotech-twitterverse-3/2010-03-13T19:49:25+00:00monthlyhttp://crossborderbiotech.ca/2010/03/08/monday-biotech-deal-review-march-8-2010/2010-03-09T06:05:57+00:00monthlyhttp://crossborderbiotech.ca/2010/03/06/this-week-in-the-twitterverse-weekend-reading-6/2010-03-06T15:31:09+00:00monthlyhttp://crossborderbiotech.ca/2010/03/05/reactions-to-canadas-2010-federal-budget/2010-03-06T01:26:13+00:00monthlyhttp://crossborderbiotech.ca/2010/03/04/canada-federal-budget-2010-goodbye-section-116/2010-09-24T22:27:20+00:00monthlyhttp://crossborderbiotech.ca/2010/03/05/friday-science-review-march-5-2010/2010-03-05T15:37:06+00:00monthlyhttp://crossborderbiotech.ca/2010/03/04/first-reactions-to-canada-federal-budget-2010-from-biotech-vc-innovation/2010-03-04T22:44:53+00:00monthlyhttp://crossborderbiotech.ca/2010/03/04/highlights-of-canadas-2010-federal-budget-for-biotech-venture-capital-and-innovation/2010-04-15T17:02:35+00:00monthlyhttp://crossborderbiotech.ca/2010/03/03/x-prize-ventures-further-into-biology-millions-may-be-up-for-grabs-for-stem-cell-diagnostics-achievements/2010-03-03T17:27:16+00:00monthlyhttp://crossborderbiotech.ca/2010/03/02/biotech-trends-update-ip-constituencies-indias-courts-nix-drug-patents-while-india-courts-y-combinator-model/2010-03-02T04:53:17+00:00monthlyhttp://crossborderbiotech.ca/2010/03/01/monday-biotech-deal-review-march-1-2010/2010-03-01T03:22:47+00:00monthlyhttp://crossborderbiotech.ca/2010/02/27/this-week-in-the-twitterverse-weekend-reading-5/2010-02-27T17:03:36+00:00monthlyhttp://crossborderbiotech.ca/2010/02/26/friday-science-review-february-26-2010/2010-02-26T17:15:09+00:00monthlyhttp://crossborderbiotech.ca/2010/02/25/cephalon-ceptions-canadian-connection-great-news-for-lumira-capital-and-mcmaster-in-250-million-biotech-option-deal/2010-02-25T17:54:04+00:00monthlyhttp://crossborderbiotech.ca/2010/02/22/monday-biotech-deal-review-february-22-2010/2010-02-22T07:32:51+00:00monthlyhttp://crossborderbiotech.ca/2010/02/20/this-week-in-the-biotech-twitterverse-weekend-reading/2010-02-21T04:13:46+00:00monthlyhttp://crossborderbiotech.ca/2010/02/19/friday-science-review-february-19-2010/2010-02-19T15:20:53+00:00monthlyhttp://crossborderbiotech.ca/2010/02/17/biotech-trends-update-personalized-medicine-the-limits-of-genomic-analysis/2010-02-17T19:20:26+00:00monthlyhttp://crossborderbiotech.ca/2010/02/16/biotech-trends-update-commercialization-by-foundations-500k-to-avi-biopharma-from-dmd-organizations/2010-02-16T21:04:02+00:00monthlyhttp://crossborderbiotech.ca/2010/02/11/should-fda-special-protocol-assessments-be-public/2010-02-16T21:03:54+00:00monthlyhttp://crossborderbiotech.ca/2010/02/15/monday-biotech-deal-review-february-15-2010/2010-02-15T03:55:49+00:00monthlyhttp://crossborderbiotech.ca/2010/02/13/this-week-in-the-twitterverse-weekend-reading-4/2010-02-13T18:59:54+00:00monthlyhttp://crossborderbiotech.ca/2010/02/12/friday-science-review-february-12-2010/2010-02-12T14:42:32+00:00monthlyhttp://crossborderbiotech.ca/2010/02/09/if-you-license-ip-in-canada-365-n-bankruptcy-insolvency-ccaa-bia-amendments/2010-02-09T17:13:06+00:00monthlyhttp://crossborderbiotech.ca/2010/02/08/monday-biotech-deal-review-february-8-2010/2010-02-08T03:53:35+00:00monthlyhttp://crossborderbiotech.ca/2010/02/06/this-week-in-the-twitterverse-weekend-reading-3/2010-02-06T22:12:37+00:00monthlyhttp://crossborderbiotech.ca/2010/02/05/friday-science-review-february-5-2010/2010-02-05T14:43:32+00:00monthlyhttp://crossborderbiotech.ca/2010/02/04/biotech-trends-update-costs-savings-from-personalized-medicine-sought-by-pbms-employers-pharma-face-legal-and-privacy-hurdles/2010-02-04T18:21:51+00:00monthlyhttp://crossborderbiotech.ca/2010/02/02/biotech-trends-update-tevas-bla-for-neupoval-is-accepted-at-the-fda/http://testbio.files.wordpress.com/2010/02/paper-people.jpgpaper people2010-02-03T02:33:27+00:00monthlyhttp://crossborderbiotech.ca/2010/02/01/monday-biotech-deal-review-february-1-2010/2010-02-01T09:16:53+00:00monthlyhttp://crossborderbiotech.ca/2010/01/30/this-week-in-the-twitterverse-weekend-reading-2/2010-01-30T16:14:55+00:00monthlyhttp://crossborderbiotech.ca/2010/01/29/friday-science-review-january-29-2010/2010-01-29T15:40:28+00:00monthlyhttp://crossborderbiotech.ca/2010/01/28/biotech-trends-update-jubilants-rd-success-continues-drive-toward-innovation-in-asia/2010-01-28T16:46:52+00:00monthlyhttp://crossborderbiotech.ca/2010/01/27/current-data-on-the-state-of-biotech-in-canada/2010-01-27T14:03:15+00:00monthlyhttp://crossborderbiotech.ca/2009/07/16/new-data-shows-70-of-canadas-biotech-companies-have-under-12-months-cash-biotecanadas-new-ask-government-loans/http://testbio.files.wordpress.com/2009/07/canadian-money.jpgCanadian money2010-01-27T14:03:08+00:00monthlyhttp://crossborderbiotech.ca/2010/01/26/new-focus-on-commercialization-at-the-oicr/http://testbio.files.wordpress.com/2010/01/oicrlogo.jpgOICRlogo2010-01-26T16:29:42+00:00monthlyhttp://crossborderbiotech.ca/2009/07/15/pfizer-and-ontario-bip-program-funding-new-6-9-million-pop-cure-project-for-colon-cancer-genomics/2010-01-26T16:22:22+00:00monthlyhttp://crossborderbiotech.ca/2010/01/25/monday-biotech-deal-review-january-25-2010/2010-03-13T05:40:22+00:00monthlyhttp://crossborderbiotech.ca/2010/01/21/biotech-bailout-how-much-does-it-cost-government-to-attract-biotech-jobs/http://testbio.files.wordpress.com/2010/01/meat-grinder.jpgmeat grinder2010-01-25T05:17:36+00:00monthlyhttp://crossborderbiotech.ca/2010/01/24/this-week-in-the-twitterverse-weekend-reading/2010-01-24T18:04:28+00:00monthlyhttp://crossborderbiotech.ca/2010/01/22/friday-science-review-january-22-2010/2010-01-22T15:57:15+00:00monthlyhttp://crossborderbiotech.ca/2010/01/22/first-two-ontario-emerging-technologies-fund-oetf-ogilvy-renault-ecobee-bering-media/http://testbio.files.wordpress.com/2010/01/ontario-growth-capital-corp-logo.gifOntario Growth Capital Corp Logo2010-01-22T14:11:01+00:00monthlyhttp://crossborderbiotech.ca/2009/01/16/money-jobs/http://testbio.files.wordpress.com/2009/03/jobs-chart.jpegjobs-chart from BIOTECanadaBiotech Jobs2010-01-20T23:40:42+00:00monthlyhttp://crossborderbiotech.ca/2010/01/20/biotech-trends-update-personalized-medicine-the-case-for-diagnostics-focuses-on-cost-and-effectiveness/2010-01-20T23:19:02+00:00monthlyhttp://crossborderbiotech.ca/2010/01/18/monday-biotech-deal-review-january-18-2010/2010-01-19T12:38:27+00:00monthlyhttp://crossborderbiotech.ca/2009/06/09/monday-deal-review-june-8-2009/2010-01-18T00:00:38+00:00monthlyhttp://crossborderbiotech.ca/2010/01/15/friday-science-review-january-15-2010/2010-01-16T18:37:08+00:00monthlyhttp://crossborderbiotech.ca/2010/01/16/this-week-in-the-twitterverse-13/2010-01-16T18:37:00+00:00monthlyhttp://crossborderbiotech.ca/2010/01/14/biotech-trends-update-commercialization-by-foundations-jdrf-jj-and-dexcom-collaborate-on-artificial-pancreas/http://testbio.files.wordpress.com/2010/01/jdrf-logo.gifJDRF Logo2010-01-14T18:43:28+00:00monthlyhttp://crossborderbiotech.ca/2010/01/13/even-more-scrutiny-pending-for-pay-for-delay-generics-deals/2010-01-13T16:20:51+00:00monthlyhttp://crossborderbiotech.ca/2010/01/11/biotech-trends-update-ip-constituencies-innovators-and-generics-continue-to-blur-pharma-lines/2010-01-11T16:41:50+00:00monthlyhttp://crossborderbiotech.ca/2010/01/11/monday-biotech-deal-review-january-11-2010/2010-01-11T03:19:48+00:00monthlyhttp://crossborderbiotech.ca/2010/01/08/friday-science-review-january-8-2010/2010-01-09T18:48:41+00:00monthlyhttp://crossborderbiotech.ca/2010/01/09/this-week-in-biotech-tweets/2010-01-15T08:11:35+00:00monthlyhttp://crossborderbiotech.ca/2010/01/08/the-long-arm-of-canadas-patented-medicine-prices-review-board-pmprb/http://testbio.files.wordpress.com/2010/01/pmprb-logo1.gifPMPRB Logo2010-01-08T03:42:40+00:00monthlyhttp://crossborderbiotech.ca/2010/01/06/analyzing-the-fdas-2009-approval-statistics/2010-01-07T17:41:18+00:00monthlyhttp://crossborderbiotech.ca/2010/01/06/jeremy-grushcow-featured-in-a-globe-mail-story-about-lawyers-social-media/2010-01-07T17:40:47+00:00monthlyhttp://crossborderbiotech.ca/2010/01/03/top-10-cross-border-biotech-blog-posts-of-2009/http://testbio.files.wordpress.com/2010/01/top10.jpgTop102010-01-05T23:28:32+00:00monthlyhttp://crossborderbiotech.ca/trends-in-2009/dtc-genetic-testing/2010-01-05T16:32:30+00:00weekly0.6http://crossborderbiotech.ca/2010/01/05/biotech-trends-update-dtc-genetics-the-future-of-direct-to-consumer-genetic-testing/2010-01-07T17:44:46+00:00monthlyhttp://crossborderbiotech.ca/2010/01/04/biotech-bailout-five-reasons-ontario-needs-to-do-more-to-support-bioscience-commercialization-in-2010/http://testbio.files.wordpress.com/2010/01/hamster-on-wheel.jpgHamster on Wheel2010-01-05T16:07:41+00:00monthlyhttp://crossborderbiotech.ca/2009/02/28/allocating-spending/2010-01-04T16:48:27+00:00monthlyhttp://crossborderbiotech.ca/2010/01/04/monday-biotech-deal-review-january-4-2010/2010-01-04T14:59:56+00:00monthlyhttp://crossborderbiotech.ca/2010/01/02/this-week-in-the-twitterverse-12/2010-01-02T21:41:18+00:00monthlyhttp://crossborderbiotech.ca/2009/12/31/top-four-biotech-trends-of-2009/http://testbio.files.wordpress.com/2009/12/numbers-1-4.jpgnumbers 1-42010-01-01T02:05:43+00:00monthlyhttp://crossborderbiotech.ca/2009/12/31/biotech-trends-of-2009-three-biggest-losers/http://testbio.files.wordpress.com/2009/12/glee-loser-sue.gifGlee Loser Sue2010-01-02T07:20:40+00:00monthlyhttp://crossborderbiotech.ca/trends-in-2009/electronic-medical-records/2009-12-31T03:37:37+00:00weekly0.6http://crossborderbiotech.ca/2009/12/28/this-week-in-the-twitterverse-11/2009-12-28T14:58:21+00:00monthlyhttp://crossborderbiotech.ca/2009/12/28/monday-biotech-deal-review-gone-fishin/2009-12-28T02:50:28+00:00monthlyhttp://crossborderbiotech.ca/trends-in-2009/synthetic-biology/2009-12-23T03:29:17+00:00weekly0.6http://crossborderbiotech.ca/trends-in-2009/social-media-in-biotech-and-healthcare/2009-12-23T03:16:16+00:00weekly0.6http://crossborderbiotech.ca/2009/12/22/trends-update-social-media-healthcare-biotech-upopolis-keeps-sickkids-patients-connected/http://testbio.files.wordpress.com/2009/12/upopolis-logo.gifUpopolis Logo2009-12-23T03:15:27+00:00monthlyhttp://crossborderbiotech.ca/2009/12/21/monday-biotech-deal-review-december-21-2009/2009-12-22T01:40:48+00:00monthlyhttp://crossborderbiotech.ca/2009/12/20/this-week-in-the-twitterverse-10/2009-12-20T20:17:43+00:00monthlyhttp://crossborderbiotech.ca/2009/12/18/friday-science-review-december-18-2009/2009-12-18T14:53:09+00:00monthlyhttp://crossborderbiotech.ca/2009/12/18/bioms-new-directions-buys-48-of-spectral-diagnostics-still-has-dry-powder/2009-12-18T06:06:33+00:00monthlyhttp://crossborderbiotech.ca/2009/12/15/biotech-trends-electronic-health-records-emr-more-cost-benefit-analysis-telemedicine-implementation-security/http://testbio.files.wordpress.com/2009/12/atalogo_yellowsnake.jpgATALogo_YellowSnake2009-12-16T00:19:00+00:00monthlyhttp://crossborderbiotech.ca/2009/12/12/this-week-in-the-twitterverse-9/2009-12-15T05:00:20+00:00monthlyhttp://crossborderbiotech.ca/2009/12/14/monday-biotech-deal-review-december-14-2009/2009-12-14T13:46:58+00:00monthlyhttp://crossborderbiotech.ca/2009/12/11/friday-science-review-december-11-2009-2/2009-12-11T16:00:41+00:00monthlyhttp://crossborderbiotech.ca/2009/12/09/biotech-trends-in-2010-top-three-reasons-why-biotech-companies-should-use-social-media/2011-11-14T19:37:01+00:00monthlyhttp://crossborderbiotech.ca/2009/12/04/friday-science-review-december-4-2009/2009-12-11T15:50:03+00:00monthlyhttp://crossborderbiotech.ca/2009/12/02/no-preemption-no-problem-state-supreme-courts-wade-into-drug-and-device-preemption/2009-12-11T15:49:57+00:00monthlyhttp://crossborderbiotech.ca/2009/12/01/biotech-trends-commercialization-by-non-profits-new-initiatives-from-als-organizations-jdrf-canada/2009-12-11T15:49:51+00:00monthlyhttp://crossborderbiotech.ca/2009/11/30/supreme-court-hears-oral-arguments-in-false-claims-act-whistleblower-case/2009-12-11T15:49:43+00:00monthlyhttp://crossborderbiotech.ca/2009/12/08/canadian-science-policy-conference-video-bruce-alberts-preston-manning-and-other-luminaries/http://testbio.files.wordpress.com/2009/12/science-policy-conference-panel.jpgScience Policy Conference Panel2009-12-08T17:45:35+00:00monthlyhttp://crossborderbiotech.ca/2009/12/07/monday-biotech-deal-review-december-7-2009/2009-12-08T07:13:01+00:00monthlyhttp://crossborderbiotech.ca/2009/12/06/this-week-in-the-twitterverse-8/2009-12-06T16:34:23+00:00monthlyhttp://crossborderbiotech.ca/2009/11/30/monday-canada-biotech-deal-review-november-30-2009/2009-12-01T05:23:07+00:00monthlyhttp://crossborderbiotech.ca/2009/11/30/three-need-to-know-canadian-patent-decisions-that-impact-pharma-biotech-and-generics-companies/2009-11-30T22:28:11+00:00monthlyhttp://crossborderbiotech.ca/2009/11/27/friday-science-review-november-27-2009/2009-11-30T22:24:16+00:00monthlyhttp://crossborderbiotech.ca/2009/11/27/biotech-trends-update-synthetic-biology-smallest-genome-may-not-provide-the-best-roadmap/2009-11-30T22:24:06+00:00monthlyhttp://crossborderbiotech.ca/2009/11/20/friday-science-review-november-20-2009/2009-11-30T22:24:00+00:00monthlyhttp://crossborderbiotech.ca/2009/11/29/this-week-in-the-twitterverse-7/2009-11-30T04:30:41+00:00monthlyhttp://crossborderbiotech.ca/2009/11/26/personalized-medicine-had-a-big-month/2009-11-30T03:34:21+00:00monthlyhttp://crossborderbiotech.ca/2009/11/23/monday-canada-biotech-deal-review-november-23-2009/2009-11-24T11:58:07+00:00monthlyhttp://crossborderbiotech.ca/2009/11/18/fda-meeting-on-the-internet-social-media-and-online-drug-marketing/http://testbio.files.wordpress.com/2009/11/fda-twitter.pngFDA Twitter2009-11-24T05:19:33+00:00monthlyhttp://crossborderbiotech.ca/2009/11/21/this-week-in-the-biotech-twitterverse-2/2009-11-21T18:52:09+00:00monthlyhttp://crossborderbiotech.ca/2009/11/20/new-early-stage-funding-ontario-genomics-institutes-pre-commercialization-business-development-fund-calls-for-2010-applications/http://testbio.files.wordpress.com/2009/11/ogi-banner-contact03-e1258697809146.jpgOGI banner-contact032009-11-20T06:42:08+00:00monthlyhttp://crossborderbiotech.ca/2009/11/19/jeremy-grushcow-quoted-by-lexpert-on-social-media/2009-11-19T23:34:20+00:00monthlyhttp://crossborderbiotech.ca/2009/11/17/two-health-biotech-research-prize-progams-name-2009-awardees-cihr/http://testbio.files.wordpress.com/2009/11/prix-galien-cihr-prize-logo.jpgPrix Galien – CIHR Prize Logo2009-11-18T05:45:41+00:00monthlyhttp://crossborderbiotech.ca/2009/11/16/monday-canada-biotech-deal-review-november-16-2009/2009-11-17T02:11:38+00:00monthlyhttp://crossborderbiotech.ca/2009/11/14/this-week-in-the-twitterverse-6/2009-11-15T02:13:10+00:00monthlyhttp://crossborderbiotech.ca/2009/11/13/friday-the-13th-science-review-november-13-2009/2009-11-13T16:37:42+00:00monthlyhttp://crossborderbiotech.ca/2009/11/12/ontario-h1n1-swine-flu-update-november-10-2009-212-hospitalized-seven-dead/http://testbio.files.wordpress.com/2009/11/ontario-swine-flu-cases-week-43.jpgOntario Swine Flu Cases Week 432009-11-13T03:25:37+00:00monthlyhttp://crossborderbiotech.ca/2009/11/12/trends-update-ip-constituencies-novartis-ceo-vasella-calls-upcoming-gleevec-decision-a-turning-point-for-rd-in-india/2009-11-12T22:05:19+00:00monthlyhttp://crossborderbiotech.ca/2009/11/12/trends-update-electronic-medical-records-ontarios-new-emr-adoption-program/2009-11-18T18:27:34+00:00monthlyhttp://crossborderbiotech.ca/2009/11/09/canada-biotech-deals-november-9-2009/2009-11-09T05:49:49+00:00monthlyhttp://crossborderbiotech.ca/2009/11/08/twitter-biotech-tweets-this-week/2009-11-08T21:59:57+00:00monthlyhttp://crossborderbiotech.ca/2009/11/06/american-medical-isotopes-production-act-of-2009-passed-by-house-of-representatives/2009-11-06T19:41:05+00:00monthlyhttp://crossborderbiotech.ca/2009/11/06/friday-science-review-november-6-2009/2009-11-06T19:27:43+00:00monthlyhttp://crossborderbiotech.ca/2009/11/04/canada-merck-schering-plough-transaction-closing-announcement/2009-11-06T19:27:35+00:00monthlyhttp://crossborderbiotech.ca/2009/11/03/biotech-trends-update-ip-constituencies-china-on-the-rise-as-an-ip-enforcer/2009-11-03T18:08:16+00:00monthlyhttp://crossborderbiotech.ca/2009/11/03/monday-canadian-biotech-deal-review-november-2-2009/2009-11-03T08:10:23+00:00monthlyhttp://crossborderbiotech.ca/2009/10/26/monday-biotech-deal-review-october-25-2009/2009-11-03T08:00:57+00:00monthlyhttp://crossborderbiotech.ca/2009/09/28/monday-deal-review-september-28-2009/2009-11-03T05:52:26+00:00monthlyhttp://crossborderbiotech.ca/2009/09/14/monday-biotech-deal-review-september-14-2009/2009-11-03T04:23:37+00:00monthlyhttp://crossborderbiotech.ca/2009/10/30/friday-science-review-october-30-2009/2009-11-01T23:46:06+00:00monthlyhttp://crossborderbiotech.ca/2009/10/31/this-week-in-the-biotech-twitterverse/2009-11-01T03:03:20+00:00monthlyhttp://crossborderbiotech.ca/2009/10/31/ontario-h1n1-swine-flu-update-october-31-all-indicators-still-increasing-2-new-deaths-10-toronto-clinics/http://testbio.files.wordpress.com/2009/10/ontario-swine-flu-cases-total-october-30-2009.jpgOntario Swine Flu Cases total October 30 20092009-11-01T02:39:18+00:00monthlyhttp://crossborderbiotech.ca/2009/10/29/gairdner-breakfast-nobel-and-gairdner-winners-discuss-biotech-and-pharmas-pipeline-problems/2009-10-30T03:05:56+00:00monthlyhttp://crossborderbiotech.ca/2009/10/28/bruce-alberts-two-strategies-to-promote-the-impact-of-science-on-policy/2009-10-29T23:35:27+00:00monthlyhttp://crossborderbiotech.ca/2009/10/27/ontario-h1n1-swine-flu-update-october-27-vaccine-is-on-the-way/http://testbio.files.wordpress.com/2009/10/ontario-swine-flu-cases-october-21-2009.jpgOntario Swine Flu Cases October 21 20092009-10-29T14:25:57+00:00monthlyhttp://crossborderbiotech.ca/2009/10/26/trends-update-electronic-medical-records-pogue-mugs-on-cbs-and-interviews-blumenthal-while-australia-shows-how-its-done/2009-10-26T07:43:03+00:00monthlyhttp://crossborderbiotech.ca/2009/10/25/a-third-rems-advantage-allergan-says-rems-for-botox-requires-off-label-communication/2009-10-26T07:39:01+00:00monthlyhttp://crossborderbiotech.ca/2009/10/23/friday-science-review-october-23-2009/2009-10-26T07:38:53+00:00monthlyhttp://crossborderbiotech.ca/2009/10/20/preventing-bias-in-comparative-effectiveness-research/2009-10-26T07:38:38+00:00monthlyhttp://crossborderbiotech.ca/2009/10/19/canada-biotech-deal-review-october-18-2009/2009-10-26T03:29:33+00:00monthlyhttp://crossborderbiotech.ca/2009/10/24/biotech-tweets-this-week/2009-10-24T18:48:26+00:00monthlyhttp://crossborderbiotech.ca/2009/10/19/dreaming-of-rems-a-second-reason-why-rems-might-be-good-for-biotech-and-pharma/2009-10-19T20:26:03+00:00monthlyhttp://crossborderbiotech.ca/2009/10/16/friday-science-review-october-16-2009/2009-10-18T01:08:32+00:00monthlyhttp://crossborderbiotech.ca/2009/10/17/this-weeks-biotech-tweets/2009-10-17T17:02:18+00:00monthlyhttp://crossborderbiotech.ca/2009/10/15/the-state-of-united-states-follow-on-biologics-exclusivity-legislation/2009-10-16T03:49:03+00:00monthlyhttp://crossborderbiotech.ca/2009/10/12/monday-biotech-deal-review-october-12-2009/2009-10-15T12:34:27+00:00monthlyhttp://crossborderbiotech.ca/2009/10/14/new-uk-bioscience-park-features-open-innovation-is-brought-to-you-by-gsk-the-uk-government-the-wellcome-trust-and-the-eeda/2009-10-15T03:05:36+00:00monthlyhttp://crossborderbiotech.ca/2009/10/13/a-new-online-resource-for-canadian-patients-medschoolforyou-com/http://testbio.files.wordpress.com/2009/10/medschoolforyou-logo1.jpgMedSchoolForYou Logo2009-10-13T19:23:50+00:00monthlyhttp://crossborderbiotech.ca/2009/10/11/this-week-in-the-twitterverse-5/2009-10-13T03:32:48+00:00monthlyhttp://crossborderbiotech.ca/2009/10/08/quebecs-122-million-new-biopharmaceutical-strategy-includes-30-million-for-genomics-may-include-sred-tax-credit-financing/http://testbio.files.wordpress.com/2009/10/accueil-biopharma-en.jpgaccueil-biopharma-en2009-10-10T03:41:14+00:00monthlyhttp://crossborderbiotech.ca/2009/10/09/friday-science-review-october-9-2009/2009-10-10T03:15:05+00:00monthlyhttp://crossborderbiotech.ca/2009/10/07/mimetogen-pharmaceuticals-sews-up-phase-i-financing/2009-10-07T17:48:38+00:00monthlyhttp://crossborderbiotech.ca/2009/10/06/biotech-trends-in-2010-get-an-early-start-at-ogis-synthetic-biology-conference/http://testbio.files.wordpress.com/2009/10/ogi-syntheticbiology1.pngOGI syntheticbiology2009-10-06T19:25:45+00:00monthlyhttp://crossborderbiotech.ca/2009/10/05/monday-biotech-deal-review-october-4-2009/2009-10-05T15:23:53+00:00monthlyhttp://crossborderbiotech.ca/2009/10/03/this-week-in-the-twitterverse-4/2009-10-05T05:03:33+00:00monthlyhttp://crossborderbiotech.ca/2009/10/02/friday-science-review-october-2-2009/2009-10-05T05:03:19+00:00monthlyhttp://crossborderbiotech.ca/2009/10/01/trends-update-innovation-in-india-forbes-profile-of-indias-glenmark-pharmaceuticals-sets-an-example-for-canadian-innovation/2009-10-05T05:03:10+00:00monthlyhttp://crossborderbiotech.ca/2009/09/29/jeremy-grushcows-article-appears-in-counsel-to-counsel-magazines-life-sciences-feature/http://testbio.files.wordpress.com/2009/09/jeremy-bw.jpgJeremy B&W2009-10-02T04:49:48+00:00monthlyhttp://crossborderbiotech.ca/2009/09/30/in-praise-of-universal-coverage-from-a-fan-of-personalized-medicine/2009-10-01T17:02:27+00:00monthlyhttp://crossborderbiotech.ca/2009/09/29/biotech-trends-for-2010-crowdsourced-edition/2009-09-30T20:04:08+00:00monthlyhttp://crossborderbiotech.ca/2009/09/29/trends-update-ip-constituencies-india-ma-spurs-pricing-concerns/2009-09-29T04:55:51+00:00monthlyhttp://crossborderbiotech.ca/2009/09/25/friday-science-review-september-25-2009/2009-09-29T04:25:17+00:00monthlyhttp://crossborderbiotech.ca/2009/09/25/next-steps-for-cardiome-activated-protein-c-program-will-seek-other-funding/2009-09-25T20:55:13+00:00monthlyhttp://crossborderbiotech.ca/2009/08/31/monday-deal-review-august-31-2009/2009-09-25T19:59:48+00:00monthlyhttp://crossborderbiotech.ca/2009/09/24/trends-update-commercialization-by-nonprofit-foundations-ico-cpdd-deal-plus-mjff-comes-to-canada/2009-09-24T21:53:14+00:00monthlyhttp://crossborderbiotech.ca/2009/09/24/trends-update-personalized-medicine-montreal-cro-ethica-licenses-artificial-intelligence-data-analysis-product-for-stratification/2009-09-24T20:24:43+00:00monthlyhttp://crossborderbiotech.ca/2009/09/24/mds-files-proxy-circular-for-sale-of-analytical-technologies-business-to-danaher/2009-09-24T20:24:29+00:00monthlyhttp://crossborderbiotech.ca/2009/09/23/trends-update-personalized-medicine-merck-strategy-head-skeptical/2009-09-23T14:37:34+00:00monthlyhttp://crossborderbiotech.ca/2009/09/22/dani-peters-featured-in-california-healthcare-institute-podcast-on-strategies-for-government-funding/2009-10-08T18:57:17+00:00monthlyhttp://crossborderbiotech.ca/2009/09/21/monday-biotech-deal-review-september-21-2009/2009-09-21T13:23:59+00:00monthlyhttp://crossborderbiotech.ca/2009/09/20/this-week-in-the-twitterverse-3/2009-09-21T04:50:08+00:00monthlyhttp://crossborderbiotech.ca/2009/07/13/monday-deal-review-july-12-2009/2009-09-21T04:16:43+00:00monthlyhttp://crossborderbiotech.ca/2009/09/18/friday-science-review-september-18-2009/http://testbio.files.wordpress.com/2009/09/brainy.jpgbrainy2009-09-21T04:07:20+00:00monthlyhttp://crossborderbiotech.ca/2009/09/17/oetf-awards-service-provider-contracts-to-northwater-and-covington/2009-09-17T23:13:04+00:00monthlyhttp://crossborderbiotech.ca/2009/09/17/obio-panel-presents-oetf-and-bip-information/2009-09-17T23:12:03+00:00monthlyhttp://crossborderbiotech.ca/2009/09/17/has-nrc-irap-run-out-of-2009-grant-money/2009-10-02T22:21:30+00:00monthlyhttp://crossborderbiotech.ca/2009/09/17/update-released-by-patheons-special-commmittee/2009-09-17T14:56:59+00:00monthlyhttp://crossborderbiotech.ca/2009/09/16/is-the-ipo-window-open-for-biotech-and-pharma-talecris-and-anthera-aim-to-find-out/2009-09-17T03:09:36+00:00monthlyhttp://crossborderbiotech.ca/2009/09/15/trends-update-comparative-effectiveness-and-personalized-medicine-is-canada-ahead-of-the-u-s-in-the-use-of-her2-testing-for-personalized-breast-cancer-treatment/2010-01-15T08:02:49+00:00monthlyhttp://crossborderbiotech.ca/2009/09/15/trends-update-ip-constituencies-amylin-partners-with-biocon-perkinelmer-buys-access-and-capacity-in-india-and-china/2009-09-15T21:10:44+00:00monthlyhttp://crossborderbiotech.ca/2009/09/13/this-week-in-the-twitterverse-2/2009-09-14T00:43:56+00:00monthlyhttp://crossborderbiotech.ca/2009/09/13/trends-update-ip-constituencies-rotman-article-explores-canadian-biotech-collaborations-with-developing-countries/http://testbio.files.wordpress.com/2009/09/collaborations-article-nbt0909-806-f4.gifCollaborations article – nbt0909-806-F42009-09-13T20:41:15+00:00monthlyhttp://crossborderbiotech.ca/2009/09/11/friday-science-review-september-11-2009/2009-09-11T17:39:26+00:00monthlyhttp://crossborderbiotech.ca/2009/09/11/revised-fda-warning-letters-webpage-to-feature-close-out-letters/http://testbio.files.wordpress.com/2009/09/fda_logo_only.giffda_logo_only2009-09-11T06:45:12+00:00monthlyhttp://crossborderbiotech.ca/2009/09/09/u-s-stimulus-stimulates-health-care-and-academic-jobs/2009-09-09T20:52:35+00:00monthlyhttp://crossborderbiotech.ca/2009/08/28/friday-science-review-august-28-2009/2009-09-09T14:00:38+00:00monthlyhttp://crossborderbiotech.ca/2009/08/28/patheon-special-committee-responds-to-jll-statements/2009-09-09T14:00:31+00:00monthlyhttp://crossborderbiotech.ca/2009/09/01/new-york-times-brody-counsels-dtc-genomics-caution/2009-09-09T14:00:24+00:00monthlyhttp://crossborderbiotech.ca/2009/09/02/bioms-and-lilly-terminate-dirucotide-agreement/2009-09-09T14:00:18+00:00monthlyhttp://crossborderbiotech.ca/2009/09/02/50-million-to-bdc-for-ontario-tech-investments-will-collaborate-with-ontario-venture-capital-fund/2009-09-09T14:00:11+00:00monthlyhttp://crossborderbiotech.ca/2009/09/03/mds-selling-its-analytical-technologies-business-for-650-million-intends-to-sell-pharma-services-business-next/2009-09-09T14:00:02+00:00monthlyhttp://crossborderbiotech.ca/2009/09/04/friday-science-review-september-4-2009/2009-09-11T05:34:24+00:00monthlyhttp://crossborderbiotech.ca/2009/09/09/ill-drink-to-that-genome-bc-and-genome-canada-launch-3-4-million-grape-and-wine-genomics-project/2009-09-09T13:57:54+00:00monthlyhttp://crossborderbiotech.ca/2009/09/07/labour-day-monday-deal-review-returns-with-a-double-edition-next-week/2009-09-08T00:15:33+00:00monthlyhttp://crossborderbiotech.ca/2009/09/06/this-week-in-the-twitterverse/2009-09-07T21:16:47+00:00monthlyhttp://crossborderbiotech.ca/2009/07/06/monday-deal-review-july-6-2009/2009-09-04T00:15:19+00:00monthlyhttp://crossborderbiotech.ca/2009/08/27/mid-atlantic-bio-call-for-emerging-company-presenters/http://testbio.files.wordpress.com/2009/08/mid-atlantic-bio-logo.jpgMid-Atlantic Bio Logo2009-08-28T03:17:50+00:00monthlyhttp://crossborderbiotech.ca/2009/08/27/rumoured-omeros-ipo-might-signal-newly-opened-window/2009-08-27T04:17:56+00:00monthlyhttp://crossborderbiotech.ca/2009/08/25/trends-update-comparative-effectiveness-with-insufficient-evidence-tie-should-go-to-the-patient/2009-08-27T04:03:53+00:00monthlyhttp://crossborderbiotech.ca/2009/08/21/lonza-offers-460-million-for-patheon-jll-rejects/2009-08-27T04:03:35+00:00monthlyhttp://crossborderbiotech.ca/2009/08/21/takeda-canadas-opening-move-reacquire-rights-to-diabetes-drug-actos-from-eli-lilly-canada/2009-08-27T04:03:24+00:00monthlyhttp://crossborderbiotech.ca/2009/08/24/monday-deal-review-august-24-2009/2009-08-24T18:16:09+00:00monthlyhttp://crossborderbiotech.ca/2009/08/21/friday-science-review-august-21-2009/2009-08-21T18:35:28+00:00monthlyhttp://crossborderbiotech.ca/2009/08/21/nrc-irap-is-on-a-roll-7-biotech-investments-in-7-weeks/http://testbio.files.wordpress.com/2009/08/nrc-irap-logo.jpgNRC-IRAP Logo2009-08-21T18:25:19+00:00monthlyhttp://crossborderbiotech.ca/2009/08/19/trends-update-dtc-genetic-tests-nova-sciencenow-program-takes-a-look/2009-08-19T19:12:45+00:00monthlyhttp://crossborderbiotech.ca/2009/08/18/interview-with-garrett-herman-yeilds-more-detail-on-the-lom-bioquest-joint-venture/2009-08-19T19:05:53+00:00monthlyhttp://crossborderbiotech.ca/2009/08/17/monday-deal-review-august-17-2009/2009-08-18T19:07:07+00:00monthlyhttp://crossborderbiotech.ca/2009/08/17/trends-update-personalized-medicine-and-comparative-effectiveness-hepc-treatment-gap-leukaemia-genetics-and-beckman-coulter-genomics/2009-08-18T17:07:31+00:00monthlyhttp://crossborderbiotech.ca/2009/08/17/another-biotech-windfall-from-the-sift-tax-vasogen-molts-for-cervus-and-merges-with-intellipharmaceutics-shareholders-applaud/2009-08-18T16:40:07+00:00monthlyhttp://crossborderbiotech.ca/2009/08/12/q3-is-looking-up-for-biotech-emdeon-cumberland-domain-lom-bioquest-oetf/2009-08-17T02:32:15+00:00monthlyhttp://crossborderbiotech.ca/2009/08/10/monday-deal-review-august-10-2009/2009-08-16T22:19:58+00:00monthlyhttp://crossborderbiotech.ca/2009/08/14/friday-science-review-august-14-2009/2009-08-14T16:09:17+00:00monthlyhttp://crossborderbiotech.ca/2009/08/13/trends-update-dtc-genetic-testing-state-law-survey-of-false-advertising-laws/2009-08-14T15:21:00+00:00monthlyhttp://crossborderbiotech.ca/2009/02/10/rep-waxman-reigel-v-medtronic-and-wyeth-v-levine/2009-08-13T17:10:25+00:00monthlyhttp://crossborderbiotech.ca/2009/08/12/tbi-mentorship-program-announced/http://testbio.files.wordpress.com/2009/08/tbimentorshiplogo.jpgTBIMentorshipLogo2009-08-13T01:24:20+00:00monthlyhttp://crossborderbiotech.ca/2009/08/11/trends-update-personalized-effectiveness-amgen-gets-prospective-data-to-back-kras-vectibix-plan/2009-08-11T18:23:12+00:00monthlyhttp://crossborderbiotech.ca/2009/08/11/cumberland-ends-bio-ipo-drought-but-prices-under-range-next-up-emdeon/2009-08-11T15:21:08+00:00monthlyhttp://crossborderbiotech.ca/2009/08/08/this-week-in-the-twitterverse-august-8-2009/2009-08-08T12:40:59+00:00monthlyhttp://crossborderbiotech.ca/2009/08/07/a-big-week-for-confirmations-sotomayor-collins-kappos-movin-on-up/2009-08-07T21:49:32+00:00monthlyhttp://crossborderbiotech.ca/2009/08/05/trends-update-electronic-medical-records-salesforce-com-clouds-the-emr-field/2009-08-07T13:40:48+00:00monthlyhttp://crossborderbiotech.ca/2009/08/06/trends-update-electronic-medical-records-presidents-council-of-advisors-on-science-and-technology-pcast-meeting-on-health-it/2009-08-07T13:38:34+00:00monthlyhttp://crossborderbiotech.ca/2009/08/06/q2-venture-capital-numbers-do-not-look-so-rosy-in-canada/2009-08-07T13:35:20+00:00monthlyhttp://crossborderbiotech.ca/2009/08/07/friday-science-review-august-7-2009/2009-08-07T13:31:42+00:00monthlyhttp://crossborderbiotech.ca/2009/07/22/do-the-q2-venture-capital-numbers-plus-the-hgs-success-indicate-a-light-at-the-end-of-the-tunnel-for-biotech-funding/http://testbio.files.wordpress.com/2009/07/light-at-the-end-of-the-tunnel-small.jpglight at the end of the tunnel small2009-08-07T02:54:33+00:00monthlyhttp://crossborderbiotech.ca/2009/08/04/what-makes-mit-so-good-at-entrepreneurship/2009-08-04T21:07:40+00:00monthlyhttp://crossborderbiotech.ca/2009/08/03/monday-deal-review-august-3-2009/2009-08-04T15:30:12+00:00monthlyhttp://crossborderbiotech.ca/2009/07/31/ontarios-250-million-emerging-technology-fund-launches/2009-07-31T23:01:38+00:00monthlyhttp://crossborderbiotech.ca/2009/07/31/welcome-to-richard-chan/2009-07-31T17:13:04+00:00monthlyhttp://crossborderbiotech.ca/2009/07/31/friday-science-review-july-31-2009/2009-07-31T14:31:19+00:00monthlyhttp://crossborderbiotech.ca/2009/07/30/merial-in-canada-sanofi-aventis-to-buy-merck-out-for-4-billion/2009-07-31T02:27:03+00:00monthlyhttp://crossborderbiotech.ca/2009/07/30/globe-and-mail-story-on-patheon-jll-battle/2009-07-30T21:25:08+00:00monthlyhttp://crossborderbiotech.ca/2009/07/28/trends-in-2009-direct-to-consumer-genetic-tests-come-to-canada/2009-07-29T03:01:06+00:00monthlyhttp://crossborderbiotech.ca/2009/07/27/startupnorths-series-on-startup-funding-sources-in-canada/http://testbio.files.wordpress.com/2009/07/startbutton-by-flickr-user-crowbert.jpgStartButton by Flickr user crowbert2009-07-27T16:25:31+00:00monthlyhttp://crossborderbiotech.ca/2009/07/27/monday-deal-review-july-27-2009/2009-07-27T04:19:43+00:00monthlyhttp://crossborderbiotech.ca/2009/07/24/toronto-based-pe-fund-imperial-capital-raises-126-million-invests-in-irb-company-schulman/2009-07-24T19:37:25+00:00monthlyhttp://crossborderbiotech.ca/2009/07/23/bristol-myers-squibb-strikes-2-1-billion-deal-for-medarex/2009-07-23T15:56:20+00:00monthlyhttp://crossborderbiotech.ca/2009/07/21/interesting-data-on-the-value-of-patent-examiner-interviews/2009-07-22T01:12:27+00:00monthlyhttp://crossborderbiotech.ca/2009/07/21/canadas-data-exclusivity-provisions-upheld-against-court-challenge/http://testbio.files.wordpress.com/2009/07/scale_of_justicejpeg1.jpgScale_of_justiceJPEG2009-07-21T18:35:49+00:00monthlyhttp://crossborderbiotech.ca/2009/07/20/trends-update-comparative-effectiveness-and-personalized-medicine-genetic-test-identifies-patient-subpopulation-for-benefit-avoids-wasted-money-and-time-for-others-on-erbitux-vectibix/2009-07-20T15:05:21+00:00monthlyhttp://crossborderbiotech.ca/2009/07/20/monday-deal-review-july-20-2009/2009-07-20T03:45:00+00:00monthlyhttp://crossborderbiotech.ca/2009/07/19/new-tennessee-state-tax-credits-incentivize-venture-fund-investments/http://testbio.files.wordpress.com/2009/07/tennessee_state_flag.pngTennessee_state_flag2009-07-20T02:12:43+00:00monthlyhttp://crossborderbiotech.ca/2009/07/18/white-house-weekly-address-the-pitch-for-health-reform/2009-07-18T21:57:59+00:00monthlyhttp://crossborderbiotech.ca/2009/07/17/no-company-is-an-island-more-pharma-and-biotech-collaboration/http://testbio.files.wordpress.com/2009/07/island-nihoa_aerial.jpgIsland Nihoa_aerial2009-07-17T21:51:12+00:00monthlyhttp://crossborderbiotech.ca/2009/07/15/bailout-update-new-uk-life-sciences-blueprint-aims-to-promote-innovation/2009-07-15T03:35:50+00:00monthlyhttp://crossborderbiotech.ca/2009/07/14/corporate-liability-journal-article-on-wyeth-v-levine-reigel-v-medtronic-and-medtronic-v-lohr/2009-07-15T02:44:31+00:00monthlyhttp://crossborderbiotech.ca/2009/07/14/toronto-international-film-festival-tiff-2009-to-open-with-creation-a-darwin-biography/http://testbio.files.wordpress.com/2009/07/tiff-logo.gifTIFF Logo2009-07-15T19:00:09+00:00monthlyhttp://crossborderbiotech.ca/2009/07/10/bioniche-signs-mcc-deal-with-endo-pharmaceuticals-20-million-up-front-110-million-plus-supply-to-follow/2009-07-13T22:32:53+00:00monthlyhttp://crossborderbiotech.ca/2009/07/13/trends-update-biosimilars-sen-kennedy-gov-dean-and-nvca-study-all-support-12-years-of-exclusivity/2009-07-13T15:33:39+00:00monthlyhttp://crossborderbiotech.ca/2009/07/13/senate-action-on-small-business-innovation-this-week/2009-07-13T13:08:35+00:00monthlyhttp://crossborderbiotech.ca/2009/06/17/jeremy-grushcow-quoted-in-nature-biotechnology/2009-07-10T04:45:33+00:00monthlyhttp://crossborderbiotech.ca/2009/06/26/u-s-supreme-court-agrees-to-hear-false-claims-act-case/2009-07-10T04:45:04+00:00monthlyhttp://crossborderbiotech.ca/2009/07/09/700-million-close-opens-the-doors-at-teralys-capital/2009-07-10T04:26:22+00:00monthlyhttp://crossborderbiotech.ca/2009/07/09/two-initiatives-in-canada-aim-to-grow-fresh-crops-of-entrepreneurs/http://testbio.files.wordpress.com/2009/07/twitter_logo_header.pngtwitter_logo_header2009-07-13T15:00:49+00:00monthlyhttp://crossborderbiotech.ca/2009/07/10/trends-update-electronic-medical-records-ottawa-telehealth-success-privacy-fiasco-in-alberta-beta-test-in-montreal/http://testbio.files.wordpress.com/2009/07/share-button.gifShare Button2009-07-10T04:23:40+00:00monthlyhttp://crossborderbiotech.ca/2009/07/08/allosteras-17m-deal-shows-canadian-venture-capital-funding-is-available-even-as-lps-hold-back-in-the-u-s/http://testbio.files.wordpress.com/2009/07/allostera-banner.gifAllostera Banner2009-07-09T15:38:17+00:00monthlyhttp://crossborderbiotech.ca/2009/07/09/trends-update-shifting-ip-constituencies-perkin-elmer-branded-generics-mylan-biocon-and-chinas-rd-budget-all-point-to-change/2009-07-09T04:51:42+00:00monthlyhttp://crossborderbiotech.ca/2009/07/09/francis-collins-nominated-to-be-nihs-next-director/http://testbio.files.wordpress.com/2009/07/nih-logo.gifNIH Logo2009-07-09T04:13:29+00:00monthlyhttp://crossborderbiotech.ca/2009/07/06/i-131-getchyer-rrrred-hot-i-131-here/2009-07-08T03:15:39+00:00monthlyhttp://crossborderbiotech.ca/2009/07/07/trends-update-comparative-effectiveness-and-personalized-medicine-study-by-camh-in-toronto-will-integrate-genetics-pet-brain-imaging-and-pharmacology/http://testbio.files.wordpress.com/2009/07/camh-logo.gifCAMH logo2009-07-08T03:12:02+00:00monthlyhttp://crossborderbiotech.ca/2009/07/06/pubmed-central-comes-to-canada-or-vice-versa/http://testbio.files.wordpress.com/2009/07/pummed-central-logo.gifPumMed Central Logo2009-07-06T21:44:26+00:00monthlyhttp://crossborderbiotech.ca/2009/07/02/post-vacation-brain-dump-vc-and-business-news/2009-07-06T14:14:41+00:00monthlyhttp://crossborderbiotech.ca/2009/07/03/trends-update-commercialization-by-nonprofit-foundations-not-all-coming-up-roses/2009-07-03T16:24:48+00:00monthlyhttp://crossborderbiotech.ca/2009/07/02/post-vacation-brain-dump-deal-developments/2009-07-02T18:45:16+00:00monthlyhttp://crossborderbiotech.ca/2009/06/27/rems-and-generics-like-oil-and-water/2009-07-02T18:37:35+00:00monthlyhttp://crossborderbiotech.ca/2009/06/26/promotion/2009-07-02T18:37:28+00:00monthlyhttp://crossborderbiotech.ca/2009/06/29/monday-deal-review-june-29-2009/2009-07-02T18:37:00+00:00monthlyhttp://crossborderbiotech.ca/2009/07/02/post-vacation-brain-dump-canadian-developments/2009-07-02T18:36:36+00:00monthlyhttp://crossborderbiotech.ca/2009/07/02/trends-update-biosimilars-obama-administration-supports-7-year-exclusivity-period/2009-07-02T18:35:32+00:00monthlyhttp://crossborderbiotech.ca/2009/06/26/brain-dump-vacation-edition/2009-07-02T18:35:13+00:00monthlyhttp://crossborderbiotech.ca/2009/06/25/sbir-reauthorization-likely-uncertain-improvements-for-vc-backed-companies/http://testbio.files.wordpress.com/2009/06/sbir-banner.gifSBIR banner2009-06-26T03:23:34+00:00monthlyhttp://crossborderbiotech.ca/2009/06/25/gone-fishin/http://testbio.files.wordpress.com/2009/06/minnows-sign.jpgGone Fishin’2009-06-25T22:02:39+00:00monthlyhttp://crossborderbiotech.ca/2009/06/25/ogilvy-is-1/2009-06-25T14:22:25+00:00monthlyhttp://crossborderbiotech.ca/2009/06/21/weekend-science-review-abba-edition/http://testbio.files.wordpress.com/2009/06/pinky-and-the-brain.jpgPinky and the Brain2009-06-24T01:10:53+00:00monthlyhttp://crossborderbiotech.ca/2009/06/22/monday-deal-review-june-22-2009/2009-06-24T01:05:46+00:00monthlyhttp://crossborderbiotech.ca/2009/06/19/trends-update-comparative-effectiveness-and-personalized-medicine-patient-centered-outcomes-research-act-of-2009-increases-personalized-medicine-focus/2009-06-20T02:40:54+00:00monthlyhttp://crossborderbiotech.ca/2009/06/19/ontario-emerging-technologies-fund-qa-from-mri-briefing/2009-06-19T13:44:32+00:00monthlyhttp://crossborderbiotech.ca/2009/06/18/relocation-relocation-relocation-biotech-incentives-and-economic-development/2009-06-19T03:37:56+00:00monthlyhttp://crossborderbiotech.ca/2009/06/17/ontario-venture-capital-fund-does-direct-investments-too-but-still-no-biotech/2009-06-18T12:44:02+00:00monthlyhttp://crossborderbiotech.ca/2009/06/17/ontario-emerging-technologies-fund-rfp-excerpts-from-mri-presentation/2009-06-17T20:32:55+00:00monthlyhttp://crossborderbiotech.ca/2009/06/17/trends-update-nonprofits-funding-commercialization-tb-alliance-splits-development-costs-with-jj-sub-for-tb-drug/http://testbio.files.wordpress.com/2009/06/mycobacterium_tuberculosis.jpgMycobacterium_tuberculosis2009-06-17T19:33:12+00:00monthlyhttp://crossborderbiotech.ca/2009/06/16/new-funding-for-bdc-says-venture-capital-in-canada-tastes-great-kedorsky-says-less-filling/http://testbio.files.wordpress.com/2009/06/horses-mouth1.jpgHorse’s Mouth2009-06-16T04:28:25+00:00monthlyhttp://crossborderbiotech.ca/2009/06/15/trends-update-electronic-medical-records-ges-first-healthymagination-project-aims-to-speed-emr-adoption-may-also-help-ge-sell-stuff/2009-06-16T02:48:06+00:00monthlyhttp://crossborderbiotech.ca/2009/06/15/monday-deal-review-june-15-2009/2009-06-15T14:10:10+00:00monthlyhttp://crossborderbiotech.ca/2009/06/13/xenon-in-neuromed-out-merck-nets-zero-canadian-collaborations-this-week/http://testbio.files.wordpress.com/2009/06/revolving_door_sign.jpgRevolving_Door_Sign2009-06-13T04:35:23+00:00monthlyhttp://crossborderbiotech.ca/2009/06/11/health-it-in-ontario-electronic-medical-records-ehealth-procurement-need-help-online-resources-make-progress/2009-06-12T01:29:11+00:00monthlyhttp://crossborderbiotech.ca/2009/06/10/ftc-weighs-in-favoring-compromise-on-biosimilars-exclusivity-disfavoring-pay-for-delay/2009-06-12T01:32:46+00:00monthlyhttp://crossborderbiotech.ca/2009/06/10/totally-worth-357-of-your-time-totally/2009-06-12T01:27:34+00:00monthlyhttp://crossborderbiotech.ca/2009/06/11/ontario-h1n1-swine-flu-update-june-11-1562-total-cases-10-in-hospital-oh-and-its-a-pandemic/http://testbio.files.wordpress.com/2009/06/ontario-swine-flu-cases-total-june-10.pngOntario Swine Flu cases total June 102009-06-12T01:25:55+00:00monthlyhttp://crossborderbiotech.ca/2009/06/09/chalk-river-reactor-isotope-shortage-gets-timing-update-international-attention-local-solution/2009-06-09T23:22:49+00:00monthlyhttp://crossborderbiotech.ca/2009/06/01/new-mars-innovation-ceo-rafi-hofstein-will-lead-products-to-the-promised-land/http://testbio.files.wordpress.com/2009/06/bw_rafi_hofstein.jpgB&W_rafi_hofstein2009-06-08T14:16:08+00:00monthlyhttp://crossborderbiotech.ca/2009/06/05/friday-science-review-studying-for-the-bar-edition/2009-06-06T22:08:20+00:00monthlyhttp://crossborderbiotech.ca/2009/06/05/the-economist-on-white-biotechnology-aka-green-chemistry-industrial-biotechnology/http://testbio.files.wordpress.com/2009/06/bw_vegcorn.pngB&W_VegCorn2009-06-05T02:56:26+00:00monthlyhttp://crossborderbiotech.ca/2009/06/03/mri-rfp-iso-for-emerging-technology-fund/http://testbio.files.wordpress.com/2009/06/ontario-logo.pngOntario Logo2009-06-04T16:23:57+00:00monthlyhttp://crossborderbiotech.ca/2009/06/03/ontario-h1n1-swine-flu-update-june-3-two-deaths-894-total-cases/http://testbio.files.wordpress.com/2009/06/ontario-swine-flu-cases-june-3.jpgOntario Swine Flu cases June 32009-06-04T16:15:37+00:00monthlyhttp://crossborderbiotech.ca/2009/06/04/patent-licenses-litigated-lately-transcore-v-etc-and-euclid-chemical-v-vector-corrosion/http://testbio.files.wordpress.com/2009/06/horton-crop.pngHorton Crop2009-06-04T16:08:22+00:00monthlyhttp://crossborderbiotech.ca/2009/06/04/novel-deal-structures-becoming-more-common/http://testbio.files.wordpress.com/2009/06/outside-the-box.pngOutside the Box2009-06-04T14:09:45+00:00monthlyhttp://crossborderbiotech.ca/2009/06/02/women-in-math-and-technology-biological-equals/http://testbio.files.wordpress.com/2009/06/sexequality.pngSexEquality2009-08-18T23:42:03+00:00monthlyhttp://crossborderbiotech.ca/2009/06/01/he-loves-me-he-loves-me-not-csl-gets-mixed-messages-from-uncle-sam/http://testbio.files.wordpress.com/2009/06/godward-he_loves_me2c_he_loves_me_not-1896.jpgGodward-He_Loves_Me%2C_He_Loves_Me_Not-18962009-06-02T01:05:04+00:00monthlyhttp://crossborderbiotech.ca/2009/06/01/monday-deal-review-june-1-2009/http://testbio.files.wordpress.com/2009/06/bw_bignickel.pngB&W_BigNickel2009-06-02T01:02:04+00:00monthlyhttp://crossborderbiotech.ca/2009/05/29/friday-science-review-infectious-disease-edition/http://testbio.files.wordpress.com/2009/05/welcometospore1.pngWelcometoSpore2009-06-01T04:55:03+00:00monthlyhttp://crossborderbiotech.ca/2009/05/29/trends-update-ip-constituencies-rumors-about-gsk-shantha-biotech/http://testbio.files.wordpress.com/2009/05/bw_blankmap-world-noborders1.pngB&W_BlankMap-World-noborders2009-06-05T19:51:06+00:00monthlyhttp://crossborderbiotech.ca/2009/05/31/trends-update-personalized-medicine-dxs-latest-companion-diagnostics-deal/http://testbio.files.wordpress.com/2009/05/dna_sequence1.pngB&W_DNA_sequence2009-06-01T04:08:58+00:00monthlyhttp://crossborderbiotech.ca/trends-in-2009/patent-reform/2009-05-31T17:42:05+00:00weekly0.6http://crossborderbiotech.ca/2009/05/29/flow-through-shares-for-cleantech-and-biotech-in-canada/http://testbio.files.wordpress.com/2009/05/800px-sieve.png800px-Sieve2009-05-29T04:42:08+00:00monthlyhttp://crossborderbiotech.ca/2009/05/27/ivbs-great-take-on-the-gsk-pfizer-hiv-joint-venture/2009-05-29T04:41:42+00:00monthlyhttp://crossborderbiotech.ca/2009/05/27/iiroc-and-finra-sitting-in-a-tree-w-h-i-s-t-l-e-b-l-o-w-i-n-g/http://testbio.files.wordpress.com/2009/05/whistles.pngWhistles2009-05-29T04:41:29+00:00monthlyhttp://crossborderbiotech.ca/2009/05/26/genome-bc-and-proof-launch-phase-two-of-biomarkers-in-transplantation/http://testbio.files.wordpress.com/2009/05/recycleme.jpgRecycleMe2009-05-29T04:41:16+00:00monthlyhttp://crossborderbiotech.ca/2009/05/26/patheon-and-jll-head-back-to-court/http://testbio.files.wordpress.com/2009/05/hockey_fight1.jpgHockey_fight2009-05-29T04:40:59+00:00monthlyhttp://crossborderbiotech.ca/2009/05/26/ontario-swine-flu-update-may-26-first-death-352-total-cases/http://testbio.files.wordpress.com/2009/05/ontario-swine-flu-cases-may-25.jpgAverage number of Ontario Swine Flu cases May 252009-05-29T04:40:44+00:00monthlyhttp://crossborderbiotech.ca/2009/05/25/more-new-canadian-tech-vc-funding/http://testbio.files.wordpress.com/2009/05/bdc-logo.jpgBDC Logo2009-05-25T21:52:13+00:00monthlyhttp://crossborderbiotech.ca/2009/05/25/opposites-are-majorly-histo-compatible/http://testbio.files.wordpress.com/2009/05/love_heart.pngLove_heart2009-05-25T21:52:04+00:00monthlyhttp://crossborderbiotech.ca/2009/05/25/monday-deal-review-may-25-2009/2009-05-25T21:50:09+00:00monthlyhttp://crossborderbiotech.ca/2009/05/21/data-gov-empiricists-start-your-engines/http://testbio.files.wordpress.com/2009/05/fed-budget-2000-chart.gifFed-budget-2000-chart2009-05-25T21:48:47+00:00monthlyhttp://crossborderbiotech.ca/2009/05/22/friday-science-review-timing-is-everything-edition/2009-05-25T21:46:23+00:00monthlyhttp://crossborderbiotech.ca/2009/05/19/trends-update-electronic-medical-records-your-ehealth-future-from-cnet-news/2009-05-25T21:44:50+00:00monthlyhttp://crossborderbiotech.ca/2009/05/20/bio-2009-wednesday-keynote-lunch-panel-on-health-reform-live-ish-blog-part-2/2009-05-21T07:33:50+00:00monthlyhttp://crossborderbiotech.ca/2009/05/20/bio-2009-wednesday-keynote-lunch-panel-on-health-reform-live-ish-blog/2009-05-20T21:40:38+00:00monthlyhttp://crossborderbiotech.ca/2009/05/20/scientific-american-and-bio-worldview-scorecard-a-global-biotechnology-ranking/2009-05-20T21:37:55+00:00monthlyhttp://crossborderbiotech.ca/2009/05/20/canadas-clean-energy-fund-gets-some-details-detailed/2009-05-20T14:42:28+00:00monthlyhttp://crossborderbiotech.ca/2009/05/19/ontario-premiers-breakfast/2009-05-20T04:57:27+00:00monthlyhttp://crossborderbiotech.ca/2009/05/19/isotope-shortage-looms-as-canadas-chalk-river-reactor-shuts-down/http://testbio.files.wordpress.com/2009/05/683px-schematicky_atom.png683px-Schematicky_atom2009-05-20T02:35:05+00:00monthlyhttp://crossborderbiotech.ca/2009/05/19/bio-2009-monday-technology-transfer-breakfast/2009-05-19T18:39:39+00:00monthlyhttp://crossborderbiotech.ca/2009/05/18/monday-deal-review-may-18-2009/2009-05-26T14:04:35+00:00monthlyhttp://crossborderbiotech.ca/2009/05/17/friday-science-review-sunday-edition/2009-05-18T03:25:34+00:00monthlyhttp://crossborderbiotech.ca/2009/05/17/the-cross-border-biotech-blog-at-bio-2009/http://testbio.files.wordpress.com/2009/05/bio-2009.gifBIO Conference Logo2009-05-18T03:24:42+00:00monthlyhttp://crossborderbiotech.ca/2009/05/14/hearings-on-the-medical-device-safety-act-of-2009/2009-05-15T02:27:41+00:00monthlyhttp://crossborderbiotech.ca/2009/05/12/what-is-the-state-of-canadas-biotechnology-industry/2009-05-15T02:21:31+00:00monthlyhttp://crossborderbiotech.ca/2009/05/14/human-swine-flu-ontario-update-may-14-tracking-the-ontario-numbers-plus-vaccine-updates/http://testbio.files.wordpress.com/2009/05/ontario-swine-flu-cases1.jpgOntario Swine Flu cases2009-05-15T02:39:47+00:00monthlyhttp://crossborderbiotech.ca/2009/05/08/friday-science-review-old-school-and-new-school-edition/http://testbio.files.wordpress.com/2009/05/erlenmeyers.pngErlenmeyers2009-05-14T19:10:46+00:00monthlyhttp://crossborderbiotech.ca/2009/05/14/trends-update-ip-constituencies-china-moves-to-boost-biotechnology/2009-05-14T19:09:06+00:00monthlyhttp://crossborderbiotech.ca/2009/05/13/fda-has-it-in-for-double-vowels-cheerios-google-ads-targeted/http://testbio.files.wordpress.com/2009/05/cheerios-pic1.jpgCheerios pic2009-05-14T19:07:58+00:00monthlyhttp://crossborderbiotech.ca/2009/05/11/swine-flu-update-monday-may-11/2009-05-12T01:00:34+00:00monthlyhttp://crossborderbiotech.ca/2009/05/11/monday-deal-review-may-11-2009/2009-05-11T20:09:08+00:00monthlyhttp://crossborderbiotech.ca/2009/05/11/trends-update-comparative-effectiveness-to-head-to-head-or-not-to-head-to-head/http://testbio.files.wordpress.com/2009/05/goats_butting_heads_in_germany.jpgGoats_butting_heads_in_Germany2009-05-11T17:50:08+00:00monthlyhttp://crossborderbiotech.ca/2009/05/07/trends-update-electronic-medical-records-ges-global-healthcare-initiative-comes-to-canada-right-behind-telus-and-microsoft/2009-05-09T16:56:31+00:00monthlyhttp://crossborderbiotech.ca/2009/05/08/obama-budget-2010-hhs-highlights/2009-05-08T17:44:10+00:00monthlyhttp://crossborderbiotech.ca/2009/05/06/licensing-and-strategic-partnerships-in-biotechnology-and-pharma-slides-from-yesterdays-talk/http://testbio.files.wordpress.com/2009/05/ric-logo1.jpgric-logo12009-05-07T20:38:48+00:00monthlyhttp://crossborderbiotech.ca/2009/05/06/ontario-h1n1-human-swine-flu-wednesday-update/2009-05-07T20:38:36+00:00monthlyhttp://crossborderbiotech.ca/2009/05/06/trends-update-shifting-ip-constituencies-astrazenecas-rd-investment-in-indias-jubilant/2009-05-07T20:38:09+00:00monthlyhttp://crossborderbiotech.ca/2009/05/06/university-of-guelph-and-vineland-launch-new-ontario-partnership-for-applied-genomics-consumer-and-horticulture-research/http://testbio.files.wordpress.com/2009/05/niagara_grape_vines.jpgniagara_grape_vines2009-05-07T20:37:52+00:00monthlyhttp://crossborderbiotech.ca/2009/05/06/senator-grassley-update-no-to-judiciary-yes-to-lunch/2009-05-07T20:37:46+00:00monthlyhttp://crossborderbiotech.ca/2009/04/26/human-swine-influenza-update-canadian-cases-confirmed/2009-05-06T03:33:32+00:00monthlyhttp://crossborderbiotech.ca/2009/04/26/human-swine-influenza-understaffed/2009-05-06T03:32:49+00:00monthlyhttp://crossborderbiotech.ca/2009/04/27/where-i-will-be-this-week/2009-05-06T03:32:39+00:00monthlyhttp://crossborderbiotech.ca/2009/04/27/monday-deal-review-april-27-2009/2009-05-06T03:32:01+00:00monthlyhttp://crossborderbiotech.ca/2009/04/29/200th-post-state-of-the-blog/2009-05-06T03:31:30+00:00monthlyhttp://crossborderbiotech.ca/2009/04/29/biofinance-lunch-keynote-us-health-reform/2009-05-06T03:31:12+00:00monthlyhttp://crossborderbiotech.ca/2009/04/30/a-familiar-refrain-from-the-uk/2009-05-06T03:30:32+00:00monthlyhttp://crossborderbiotech.ca/2009/04/30/health-care-reform-partys-over-for-medical-imaging/http://testbio.files.wordpress.com/2009/04/mri-knee.jpgmri-knee2009-05-06T03:30:24+00:00monthlyhttp://crossborderbiotech.ca/2009/05/01/what-you-missed-while-you-were-at-biofinance/2009-05-06T03:29:35+00:00monthlyhttp://crossborderbiotech.ca/2009/05/01/friday-science-review-screening-edition/http://testbio.files.wordpress.com/2009/05/breast_cancer_awareness_263497131.jpgPink Ribbon2009-05-06T03:29:22+00:00monthlyhttp://crossborderbiotech.ca/2009/05/02/ontario-human-swine-flu-update-14-confrimed-all-mild/http://testbio.files.wordpress.com/2009/05/antigenicshift_hirescrop1.jpgantigenicshift_hirescrop12009-05-06T03:28:38+00:00monthlyhttp://crossborderbiotech.ca/2009/05/02/breakfast-talk-on-licensing-and-strategic-partnerships-tuesday-may-5/2009-05-06T03:28:26+00:00monthlyhttp://crossborderbiotech.ca/2009/05/03/swine-flu-snake-oil/2009-05-06T03:27:53+00:00monthlyhttp://crossborderbiotech.ca/2009/05/04/monday-deal-review-may-4-2009/http://testbio.files.wordpress.com/2009/05/bignickel1.jpgbignickel12009-05-06T03:27:22+00:00monthlyhttp://crossborderbiotech.ca/2009/05/04/globe-and-mail-prefers-to-hear-the-bad-news-first/2009-05-06T03:26:58+00:00monthlyhttp://crossborderbiotech.ca/2009/05/04/trends-update-electronic-medical-records-health-it-and-emr-have-an-advocate-in-new-oma-president-suzanne-strasberg/http://testbio.files.wordpress.com/2009/05/wikimedia-servers-sept04.jpgComputer Servers2009-05-06T03:26:39+00:00monthlyhttp://crossborderbiotech.ca/2009/05/04/canada-and-mars-draw-notice-on-list-of-biotechnology-clusters/http://testbio.files.wordpress.com/2009/05/800px-cia_political_world_map_2002.jpgworld_map_20022009-05-06T03:26:05+00:00monthlyhttp://crossborderbiotech.ca/2009/05/04/confirmed-human-swine-flu-cases-in-ontario-double/2009-05-06T03:25:25+00:00monthlyhttp://crossborderbiotech.ca/2009/05/05/trends-update-personalized-medicine-no-medicare-funding-for-warfarin-testing-for-now/http://testbio.files.wordpress.com/2009/05/dna_sequence.pngdna_sequence2009-05-06T03:25:08+00:00monthlyhttp://crossborderbiotech.ca/2009/05/05/human-swine-flu-ontario-update-and-other-new-info/2009-05-06T03:24:03+00:00monthlyhttp://crossborderbiotech.ca/2009/02/23/warfarin-and-personalized-medicine/2009-05-06T03:23:33+00:00monthlyhttp://crossborderbiotech.ca/2009/03/22/trends-in-2009-shifting-ip-constituencies/2009-05-05T01:22:39+00:00monthlyhttp://crossborderbiotech.ca/2009/03/09/100th-post-state-of-the-blog/2009-05-03T02:57:06+00:00monthlyhttp://crossborderbiotech.ca/2009/04/24/swine-flu-outbreak/2009-04-26T14:14:47+00:00monthlyhttp://crossborderbiotech.ca/2009/04/24/friday-science-review-walk-before-you-run-edition/http://testbio.files.wordpress.com/2009/04/i138_bacon_skeleton_col.jpgPuijila darwiniPuijila darwini2009-04-26T14:12:56+00:00monthlyhttp://crossborderbiotech.ca/2009/04/25/human-swine-influenza-saturday-cdc-call/2009-04-26T14:12:46+00:00monthlyhttp://crossborderbiotech.ca/2009/04/26/human-swine-influenza-update-world-health-organization-who-resources/2009-04-26T14:12:39+00:00monthlyhttp://crossborderbiotech.ca/2009/04/20/monday-deal-review-april-20-2009/2009-04-26T01:29:27+00:00monthlyhttp://crossborderbiotech.ca/2009/04/23/meet-the-bovine-j-craig-venter/http://testbio.files.wordpress.com/2009/04/cow1.jpgHerefordL1 Dominette 014492009-04-24T15:22:51+00:00monthlyhttp://crossborderbiotech.ca/2009/04/22/plan-b-otc/2009-04-23T23:45:32+00:00monthlyhttp://crossborderbiotech.ca/2009/04/23/wednesday-brain-dump-plant-matter-edition/2009-04-23T23:45:26+00:00monthlyhttp://crossborderbiotech.ca/2009/04/22/canadas-first-subsequent-entry-biologic/2009-04-23T05:03:03+00:00monthlyhttp://crossborderbiotech.ca/2009/04/21/ftc-proposed-rule-for-medical-record-privacy-for-non-hipaa-entities/2009-04-23T02:05:00+00:00monthlyhttp://crossborderbiotech.ca/2009/04/21/trends-update-personalized-medicine-clinical-data-on-personalized-cancer-treatment/2009-04-23T02:04:16+00:00monthlyhttp://crossborderbiotech.ca/2009/04/21/editor/2009-04-23T02:04:09+00:00monthlyhttp://crossborderbiotech.ca/2009/04/22/new-oha-site-for-ontario-hospital-performance-data/2009-04-23T02:03:24+00:00monthlyhttp://crossborderbiotech.ca/2009/04/17/friday-science-review-first-time-for-everything-edition/2009-04-21T17:00:35+00:00monthlyhttp://crossborderbiotech.ca/2009/04/20/canadian-science-funding-update-open-letter-from-canadian-scientists-generates-equal-opposite-open-letter-from-gary-goodyear/2009-04-21T16:59:43+00:00monthlyhttp://crossborderbiotech.ca/2009/04/20/new-data-in-canada-biotecanada-pwc-2009-life-sciences-forecast/2009-04-21T16:59:37+00:00monthlyhttp://crossborderbiotech.ca/2009/04/15/wednesday-brain-dump-two-of-everything-edition/2009-04-16T21:13:54+00:00monthlyhttp://crossborderbiotech.ca/2009/04/16/reactions-to-in-re-kubin-dna-patents-and-obviousness/2009-09-04T17:25:15+00:00monthlyhttp://crossborderbiotech.ca/2009/01/14/new-off-label-guidance/2009-04-16T18:32:22+00:00monthlyhttp://crossborderbiotech.ca/2009/04/15/gm-crops-report-aimed-at-a-straw-man-creates-kerfuffle/2009-04-16T07:59:02+00:00monthlyhttp://crossborderbiotech.ca/2009/04/14/some-good-clean-tech-synergy-biotech-cleantech-nanotech/2009-04-15T01:39:20+00:00monthlyhttp://crossborderbiotech.ca/2009/04/14/abbotts-abt-888-guinea-pig-first-phase-0-clinical-trial-completed/2009-04-14T18:06:49+00:00monthlyhttp://crossborderbiotech.ca/2009/04/13/monday-deal-review-april-13-2009/2009-04-14T01:30:01+00:00monthlyhttp://crossborderbiotech.ca/2009/04/13/about-the-delayed-sebelius-confirmation/2009-04-13T22:14:53+00:00monthlyhttp://crossborderbiotech.ca/2009/04/13/the-week-ahead-ftc-hearing-on-evolving-ip-marketplace/2009-04-13T22:14:17+00:00monthlyhttp://crossborderbiotech.ca/2009/04/13/new-life-sciences-industry-data/2009-04-12T05:04:21+00:00monthlyhttp://crossborderbiotech.ca/2009/04/12/bailout-updates-results-may-vary/2009-04-11T21:02:48+00:00monthlyhttp://crossborderbiotech.ca/2009/04/11/trends-update-ip-constituencies-sanofi-buys-medley-in-brazil/2009-04-11T17:49:30+00:00monthlyhttp://crossborderbiotech.ca/2009/04/11/trends-update-electronic-medical-records-military-and-vetrans-system-should-speed-adoption-standards/2009-04-11T17:36:56+00:00monthlyhttp://crossborderbiotech.ca/2009/04/10/friday-science-review-run-for-it-edition/2009-04-11T03:28:28+00:00monthlyhttp://crossborderbiotech.ca/2009/04/09/yet-another-way-canadian-employment-law-can-mess-you-up/2009-04-09T19:18:19+00:00monthlyhttp://crossborderbiotech.ca/2009/03/30/white-house-reports-on-white-house-forum-on-health-reform/2009-04-09T13:28:39+00:00monthlyhttp://crossborderbiotech.ca/2009/04/08/wednesday-brain-dump-things-that-might-surprise-you-edition/2009-04-09T03:28:59+00:00monthlyhttp://crossborderbiotech.ca/2009/04/08/cardiome-licenses-vernakalant-oral-to-merck/2009-04-09T03:25:56+00:00monthlyhttp://crossborderbiotech.ca/2009/04/08/trend-update-electronic-medical-records-view-from-himss/2009-04-09T03:25:44+00:00monthlyhttp://crossborderbiotech.ca/2009/04/05/existential-question-for-2009-is-a-virtual-company-virtually-as-good/2009-04-08T14:44:43+00:00monthlyhttp://crossborderbiotech.ca/2009/04/06/monday-deal-review-april-6-2009/2009-04-08T14:44:20+00:00monthlyhttp://crossborderbiotech.ca/2009/04/06/its-a-bird-its-a-plane-its-super-canadian-genomics-funding/2009-04-08T14:43:49+00:00monthlyhttp://crossborderbiotech.ca/2009/04/06/wait-wait-you-should-hear-this/2009-04-08T14:43:31+00:00monthlyhttp://crossborderbiotech.ca/2009/04/07/trends-in-2009-update-hospital-hits-electronic-medical-record-milestone/2009-04-08T14:42:55+00:00monthlyhttp://crossborderbiotech.ca/2009/04/08/ontario-venture-capital-fund-ovcf-scoreboard-commitments-2-biotechcleantech-0/2009-04-08T14:42:50+00:00monthlyhttp://crossborderbiotech.ca/2009/04/03/friday-science-review-good-news-bad-news-edition/2009-04-04T04:35:08+00:00monthlyhttp://crossborderbiotech.ca/2009/04/02/sibelius-senate-hearing-excerpts-from-prepared-testimony/2009-04-04T01:28:44+00:00monthlyhttp://crossborderbiotech.ca/2009/04/01/wednesday-brain-dump-deal-o-rama-edition/2009-04-03T21:13:24+00:00monthlyhttp://crossborderbiotech.ca/2009/04/03/canadian-life-sciences-vcs-lead-the-realization-parade/2009-04-03T21:11:16+00:00monthlyhttp://crossborderbiotech.ca/2009/04/02/one-week-until-passover/2009-04-03T21:09:56+00:00monthlyhttp://crossborderbiotech.ca/2009/04/03/us-unemployment-numbers-hit-25-year-high/2009-04-03T21:09:38+00:00monthlyhttp://crossborderbiotech.ca/2009/04/02/trends-in-2009-comparative-effectiveness-meets-personalized-medicine-in-the-senate/2009-04-03T21:09:06+00:00monthlyhttp://crossborderbiotech.ca/2009/03/31/essex-woodland-health-ventures-new-900-million-fund/2009-04-01T15:10:28+00:00monthlyhttp://crossborderbiotech.ca/2009/04/01/google-to-venture-into-the-life-sciences/2009-04-01T12:34:21+00:00monthlyhttp://crossborderbiotech.ca/2009/03/31/2009-gairdner-winners-announced/2009-04-01T04:53:28+00:00monthlyhttp://crossborderbiotech.ca/2009/03/31/angiotech-expands-and-reworks-baxter-coseal-deal-for-real/2009-03-31T17:29:30+00:00monthlyhttp://crossborderbiotech.ca/2009/03/31/trends-update-chinabio-and-shantha-biotech/2009-03-31T14:55:18+00:00monthlyhttp://crossborderbiotech.ca/2009/03/30/facts-theories-and-minister-of-state-for-science-and-technology-gary-goodyear/2009-03-31T14:52:59+00:00monthlyhttp://crossborderbiotech.ca/2009/03/30/theres-no-bailout-like-a-good-exit/2009-03-30T14:02:32+00:00monthlyhttp://crossborderbiotech.ca/2009/03/30/monday-deal-review-march-30-2009/2009-03-30T01:53:56+00:00monthlyhttp://crossborderbiotech.ca/2009/03/28/the-week-ahead-on-capitol-hill/2009-03-29T23:37:36+00:00monthlyhttp://crossborderbiotech.ca/2009/03/27/friday-science-review-if-you-want-to/2009-03-28T01:36:32+00:00monthlyhttp://crossborderbiotech.ca/2009/03/27/texas-funds-50-million-for-therapeutics-manufacturing-center/2009-03-27T23:51:40+00:00monthlyhttp://crossborderbiotech.ca/2009/03/27/duck/2009-03-27T23:22:09+00:00monthlyhttp://crossborderbiotech.ca/2009/03/27/canadian-ma-akela-pharma-and-nventa-to-merge-akela-shareholders-to-own-70/2009-03-27T23:22:04+00:00monthlyhttp://crossborderbiotech.ca/2009/03/27/ontario-budget-2009-initial-reactions/2009-03-27T23:21:59+00:00monthlyhttp://crossborderbiotech.ca/2009/03/26/tsx-temporary-relief-extended/2009-03-26T21:59:41+00:00monthlyhttp://crossborderbiotech.ca/2009/03/26/2009-ontario-budget-innovation-highlights/2009-03-26T21:58:51+00:00monthlyhttp://crossborderbiotech.ca/2009/03/26/beverages-tonight-in-toronto/2009-03-26T19:46:04+00:00monthlyhttp://crossborderbiotech.ca/2009/03/26/takeda-comes-to-canada/2009-09-07T22:33:36+00:00monthlyhttp://crossborderbiotech.ca/2009/03/26/ontario-budget-today/2009-03-26T19:45:44+00:00monthlyhttp://crossborderbiotech.ca/2009/03/26/roche-tenderly-completes-genentech-deal/2009-03-26T19:45:23+00:00monthlyhttp://crossborderbiotech.ca/2009/03/25/wednesday-brain-dump-around-the-world-edition/2009-03-26T19:45:11+00:00monthlyhttp://crossborderbiotech.ca/2009/03/25/disclosure-disclosure-disclosure/2009-03-26T19:44:59+00:00monthlyhttp://crossborderbiotech.ca/2009/03/25/ovcf-scoreboard-commitments-1-biotechcleantech-0/2009-03-26T19:44:52+00:00monthlyhttp://crossborderbiotech.ca/2009/03/24/science-and-technology-in-indias-election/2009-03-26T19:44:41+00:00monthlyhttp://crossborderbiotech.ca/2009/03/23/new-merck-serono-biotechnology-ventures-fund/2009-03-26T19:44:17+00:00monthlyhttp://crossborderbiotech.ca/2009/03/18/wednesday-brain-dump-march-18-2009/2009-03-26T19:42:03+00:00monthlyhttp://crossborderbiotech.ca/2009/03/20/friday-science-review-march-20-2009/2009-03-26T03:55:26+00:00monthlyhttp://crossborderbiotech.ca/2009/02/18/biotech-bailout-texas-edition/2009-03-24T18:40:48+00:00monthlyhttp://crossborderbiotech.ca/2009/03/13/changes-to-canadas-competition-act-and-investment-canada-act-become-law/2009-03-24T15:43:24+00:00monthlyhttp://crossborderbiotech.ca/2009/03/23/monday-deal-review-march-23-2009/2009-03-23T03:00:07+00:00monthlyhttp://crossborderbiotech.ca/2009/03/20/the-gary-goodyear-evolution-story-as-it-has-evolved-so-far/2009-03-20T06:31:35+00:00monthlyhttp://crossborderbiotech.ca/2009/03/19/250-million-ontario-emerging-technologies-fund-seen-raised-by-825-million-quebec-venture-capital-fund/2009-03-20T01:37:47+00:00monthlyhttp://crossborderbiotech.ca/2009/03/14/electronic-medical-records-update-walmart-solution-google-problem/2009-03-24T16:16:18+00:00monthlyhttp://crossborderbiotech.ca/2009/03/16/monday-deal-review-march-16-2009/2009-03-19T03:58:25+00:00monthlyhttp://crossborderbiotech.ca/2009/03/16/well-see-what-vc/2009-03-19T03:58:10+00:00monthlyhttp://crossborderbiotech.ca/2009/03/16/cv-therapeutics-going-once-going-twice/2009-03-19T03:56:34+00:00monthlyhttp://crossborderbiotech.ca/2009/03/17/states-step-in-to-ban-stem-cell-research/2009-03-19T03:56:20+00:00monthlyhttp://crossborderbiotech.ca/2009/03/17/anyone-else-short-on-cash/2009-03-19T03:56:06+00:00monthlyhttp://crossborderbiotech.ca/2009/03/13/friday-science-review-march-13-2009/2009-03-15T03:53:47+00:00monthlyhttp://crossborderbiotech.ca/2009/03/12/patheon-special-committee-responds/2009-03-13T20:48:58+00:00monthlyhttp://crossborderbiotech.ca/2009/03/12/ma-hooray-genentechs-and-cv-therapeutics-dreams-come-true/2009-03-12T13:12:28+00:00monthlyhttp://crossborderbiotech.ca/2009/03/11/waxman-drives-hard-bargain-on-fobs-market-exclusivity/2009-03-12T02:31:21+00:00monthlyhttp://crossborderbiotech.ca/2009/03/11/bailout-update-uk-and-canada/2009-03-12T02:28:55+00:00monthlyhttp://crossborderbiotech.ca/2009/03/10/the-face-of-cod/2009-03-12T01:28:09+00:00monthlyhttp://crossborderbiotech.ca/2009/03/11/wednesday-brain-dump-march-11-2009/2009-03-12T01:27:09+00:00monthlyhttp://crossborderbiotech.ca/2009/03/11/canadian-ma-update-jll-commences-patheon-bid-at-usd200-per-share/2009-03-12T01:27:03+00:00monthlyhttp://crossborderbiotech.ca/2009/03/10/patent-reform-live-senate-judiciary-committee-hearings/2009-03-10T19:52:38+00:00monthlyhttp://crossborderbiotech.ca/2009/03/10/sox-like-controls-for-scientific-integrity/2009-03-10T19:29:16+00:00monthlyhttp://crossborderbiotech.ca/2009/03/09/restoring-scientific-integrity-to-government-decision-making/2009-03-10T01:05:09+00:00monthlyhttp://crossborderbiotech.ca/2009/03/03/harold-varmus-on-the-daily-show/2009-03-09T19:05:22+00:00monthlyhttp://crossborderbiotech.ca/2009/03/09/merck-and-schering-plough-in-canada/2009-03-09T14:52:42+00:00monthlyhttp://crossborderbiotech.ca/2009/03/09/monday-deal-review-march-9-2009/2009-03-09T09:16:03+00:00monthlyhttp://crossborderbiotech.ca/2009/03/07/roche-genentech-update/2009-03-09T07:52:53+00:00monthlyhttp://crossborderbiotech.ca/2009/03/08/canadian-budget-reaction-boils-over/2009-03-16T22:29:12+00:00monthlyhttp://crossborderbiotech.ca/2009/03/06/stimulus-funding-from-nih/2009-03-06T15:21:13+00:00monthlyhttp://crossborderbiotech.ca/2009/03/06/friday-science-review-march-6-2009/2009-03-06T15:15:27+00:00monthlyhttp://crossborderbiotech.ca/2009/03/06/preemption-update-waxman-pallone-hit-the-ground-running/2009-03-06T07:45:42+00:00monthlyhttp://crossborderbiotech.ca/2009/03/04/wednesday-brain-dump-march-4-2009/2009-03-05T14:57:36+00:00monthlyhttp://crossborderbiotech.ca/2009/03/05/trends-in-2009-personalized-medicine-and-cancer-update/2009-03-05T04:29:40+00:00monthlyhttp://crossborderbiotech.ca/2009/03/04/supreme-court-rules-6-3-against-preemption-in-wyeth-v-levine/2009-03-04T22:16:35+00:00monthlyhttp://crossborderbiotech.ca/2009/03/04/patent-reform-act-of-2009-1/2009-09-30T00:39:21+00:00monthlyhttp://crossborderbiotech.ca/2009/03/03/obama-sebelius-and-drug-importation/2009-03-03T17:30:23+00:00monthlyhttp://crossborderbiotech.ca/2009/03/03/biotech-crop-news-crops-up-all-over/2009-03-02T23:05:26+00:00monthlyhttp://crossborderbiotech.ca/2009/03/02/sibelius-for-hhs-sibelius-for-biotech/2009-03-02T22:33:24+00:00monthlyhttp://crossborderbiotech.ca/2009/03/02/monday-deal-review-march-2-2009/2009-03-02T22:33:15+00:00monthlyhttp://crossborderbiotech.ca/2009/02/27/friday-science-review-february-27-2009/2009-02-27T22:22:27+00:00monthlyhttp://crossborderbiotech.ca/2009/02/25/wednesday-brain-dump-february-25-2009/2009-02-27T22:18:58+00:00monthlyhttp://crossborderbiotech.ca/2009/02/27/gtc-biotherapeutics-goes-for-a-regulatory-double-combo-shot/2009-02-27T21:20:22+00:00monthlyhttp://crossborderbiotech.ca/2009/02/27/bright-spot-for-canada-in-nih-gains/2009-02-27T15:53:44+00:00monthlyhttp://crossborderbiotech.ca/2009/02/26/jj-and-basilea-to-arbitrate/2009-02-27T15:53:22+00:00monthlyhttp://crossborderbiotech.ca/2009/02/24/exciting-day-today/2009-02-26T02:14:34+00:00monthlyhttp://crossborderbiotech.ca/2009/02/25/eeoc-meeting-kicks-off-gina-comment-period/2009-02-25T21:50:00+00:00monthlyhttp://crossborderbiotech.ca/2009/02/24/more-money-house-of-representatives-release-2009-spending-bill/2009-02-25T04:02:07+00:00monthlyhttp://crossborderbiotech.ca/2009/02/24/from-here-to-osgoode-and-back-again/2009-02-24T20:07:09+00:00monthlyhttp://crossborderbiotech.ca/2009/02/24/the-edison-awards/2009-02-24T17:00:12+00:00monthlyhttp://crossborderbiotech.ca/2009/02/23/being-organic-means-never-having-to-say-youre-cloned/2009-02-23T22:05:13+00:00monthlyhttp://crossborderbiotech.ca/2009/02/23/monday-deal-review-february-23-2009/2009-02-23T22:04:27+00:00monthlyhttp://crossborderbiotech.ca/2009/02/21/ma-update-2/2009-02-23T22:03:24+00:00monthlyhttp://crossborderbiotech.ca/2009/02/19/device-liability-preemption/2009-02-20T19:21:09+00:00monthlyhttp://crossborderbiotech.ca/2009/02/20/sibelius-and-biotech/2009-02-20T18:49:56+00:00monthlyhttp://crossborderbiotech.ca/2009/02/20/more-waxman-pallone-reporting-on-state-tort-liability-medical-devices-and-fda-approval/2009-02-20T18:36:39+00:00monthlyhttp://crossborderbiotech.ca/2009/02/18/wednesday-brain-dump-february-18-2009/2009-02-20T05:22:33+00:00monthlyhttp://crossborderbiotech.ca/2009/02/19/teva-decides-not-to-wait-for-biosimilars-legislation/2009-02-20T03:56:01+00:00monthlyhttp://crossborderbiotech.ca/2009/02/20/friday-science-review-february-20-2009/2009-02-20T03:10:55+00:00monthlyhttp://crossborderbiotech.ca/2009/02/19/tbi-breakfast-bio-and-biotech-in-the-state-of-georgia/2009-02-19T21:21:04+00:00monthlyhttp://crossborderbiotech.ca/2009/02/19/nih-stimulus-spending/2009-02-19T16:39:42+00:00monthlyhttp://crossborderbiotech.ca/2009/02/18/biotech-crop-news-in-eu/2009-02-19T01:12:14+00:00monthlyhttp://crossborderbiotech.ca/2009/02/18/biotech-bailout-maryland-ask/2009-02-18T19:38:13+00:00monthlyhttp://crossborderbiotech.ca/2009/02/17/personalized-medicine-the-snp-doctor/2009-02-17T20:28:44+00:00monthlyhttp://crossborderbiotech.ca/2009/02/16/comparative-effectiveness-stimulates-reactions/2009-02-17T16:52:37+00:00monthlyhttp://crossborderbiotech.ca/2009/02/17/trends-in-2009-biologics/2009-02-17T16:11:47+00:00monthlyhttp://crossborderbiotech.ca/2009/02/16/monday-deal-review-february-16-2009/2009-02-16T16:19:13+00:00monthlyhttp://crossborderbiotech.ca/2009/02/14/stimulus-bill-originalism/2009-02-14T21:29:10+00:00monthlyhttp://crossborderbiotech.ca/2009/02/11/us-stimulus-compromise/2009-02-14T21:27:40+00:00monthlyhttp://crossborderbiotech.ca/2009/02/13/friday-science-review-february-13-2009/2009-02-13T16:04:53+00:00monthlyhttp://crossborderbiotech.ca/2009/02/12/more-info-on-canadian-electronic-medical-records-implementation/2009-02-13T05:09:03+00:00monthlyhttp://crossborderbiotech.ca/2009/01/23/update-on-us-biotech-bailout/2009-02-12T22:00:16+00:00monthlyhttp://crossborderbiotech.ca/2009/01/24/trends-in-2009-personalized-medicine-just-down-the-street/2009-02-12T21:48:15+00:00monthlyhttp://crossborderbiotech.ca/2009/01/25/trends-trends-everywhere-random-gloating-ii/2009-02-12T21:47:09+00:00monthlyhttp://crossborderbiotech.ca/2009/01/26/monday-deal-review-january-26-2009/2009-02-12T21:45:15+00:00monthlyhttp://crossborderbiotech.ca/2009/01/26/pfizer-wyeth-in-canada/2009-02-12T21:44:42+00:00monthlyhttp://crossborderbiotech.ca/2009/01/26/how-not-to-cut-back/2009-02-12T21:40:19+00:00monthlyhttp://crossborderbiotech.ca/2009/01/27/flu-and-stimulus/2009-02-12T21:33:36+00:00monthlyhttp://crossborderbiotech.ca/2009/01/27/personalized-medicine-local-to-global/2009-02-12T21:31:08+00:00monthlyhttp://crossborderbiotech.ca/2009/01/27/canadian-budget/2009-02-12T21:30:27+00:00monthlyhttp://crossborderbiotech.ca/2009/01/28/wendesday-brain-dump-january-28/2009-02-12T21:29:13+00:00monthlyhttp://crossborderbiotech.ca/2009/01/28/canada-budget-reax/2009-02-12T21:27:10+00:00monthlyhttp://crossborderbiotech.ca/2009/01/29/canada-budget-reax-update/2009-02-12T21:22:33+00:00monthlyhttp://crossborderbiotech.ca/2009/01/29/dare-we-compare/2009-02-12T21:21:04+00:00monthlyhttp://crossborderbiotech.ca/2009/01/30/friday-science-review-january-30-2009/2009-02-12T21:19:34+00:00monthlyhttp://crossborderbiotech.ca/2009/01/30/its-raining-ma/2009-02-12T21:16:47+00:00monthlyhttp://crossborderbiotech.ca/2009/02/02/monday-deal-review-february-2-2009/2009-08-10T17:06:13+00:00monthlyhttp://crossborderbiotech.ca/2009/02/02/biotech-bailout-israel-edition/2009-02-12T20:56:42+00:00monthlyhttp://crossborderbiotech.ca/2009/02/02/its-raining-ma-update/2009-02-12T20:55:42+00:00monthlyhttp://crossborderbiotech.ca/2009/02/03/it-might-rain-ma-at-merck-too/2009-02-12T20:53:58+00:00monthlyhttp://crossborderbiotech.ca/2009/02/03/budget-an-innovation-shortfall/2009-02-12T20:52:42+00:00monthlyhttp://crossborderbiotech.ca/2009/02/03/funding-gap/2009-02-12T20:49:12+00:00monthlyhttp://crossborderbiotech.ca/2009/02/04/wednesday-brain-dump-february-4-2009/2009-02-12T20:47:45+00:00monthlyhttp://crossborderbiotech.ca/2009/02/04/trends-in-2009-electronic-medical-records/2009-02-12T20:46:25+00:00monthlyhttp://crossborderbiotech.ca/2009/02/05/electronic-medical-records-and-public-health/2009-02-12T20:45:37+00:00monthlyhttp://crossborderbiotech.ca/2009/02/06/introducing/2009-02-12T20:44:00+00:00monthlyhttp://crossborderbiotech.ca/2009/02/06/could-have-been-worse/2009-02-12T20:37:18+00:00monthlyhttp://crossborderbiotech.ca/2009/02/06/friday-science-review-february-6-2009/2009-02-12T20:32:01+00:00monthlyhttp://crossborderbiotech.ca/2009/02/07/senate-stimulus-good-and-bad-outcomes-for-funding-biotech/2009-02-12T20:30:36+00:00monthlyhttp://crossborderbiotech.ca/2009/02/08/bailout-france-edition/2009-02-12T20:24:17+00:00monthlyhttp://crossborderbiotech.ca/2009/02/09/monday-deal-review-february-9-2009/2009-02-12T20:22:59+00:00monthlyhttp://crossborderbiotech.ca/2009/02/10/ma-update/2009-02-12T20:20:13+00:00monthlyhttp://crossborderbiotech.ca/2009/02/11/trends-in-2009-genetically-engineered-animal-approvals/2009-02-12T20:13:28+00:00monthlyhttp://crossborderbiotech.ca/2009/02/11/wednesday-brain-dump-february-11-2009/2009-02-12T20:12:07+00:00monthlyhttp://crossborderbiotech.ca/2009/01/20/oops/2009-01-24T22:12:04+00:00monthlyhttp://crossborderbiotech.ca/2009/01/23/friday-science-review-20090123/2009-01-24T22:08:46+00:00monthlyhttp://crossborderbiotech.ca/2009/01/23/trends-in-2009-youve-got-a-friend-in/2009-01-25T02:26:17+00:00monthlyhttp://crossborderbiotech.ca/2009/01/23/bailout-bedfellows/2009-01-23T19:37:03+00:00monthlyhttp://crossborderbiotech.ca/2009/01/15/trends-patent-reform/2009-01-23T18:53:30+00:00monthlyhttp://crossborderbiotech.ca/2009/01/17/trends-random-gloating/2009-01-23T18:52:33+00:00monthlyhttp://crossborderbiotech.ca/2009/01/20/inauguration-links/2009-01-23T16:11:06+00:00monthlyhttp://crossborderbiotech.ca/2009/01/21/new-mopop-chapter-17-re-biotechnology/2009-02-26T19:10:33+00:00monthlyhttp://crossborderbiotech.ca/2009/01/16/up-to-the-minute-fda-launches-secure-supply-chain-pilot-program/2009-01-21T03:59:02+00:00monthlyhttp://crossborderbiotech.ca/2009/01/12/trends-in-2009-comparative-effectiveness-and-personalized-medicine/2009-01-20T00:08:05+00:00monthlyhttp://crossborderbiotech.ca/2009/01/12/bailout-bonanza/http://testbio.files.wordpress.com/2009/01/bailout-pic.gifbailout-pic2009-01-16T16:29:09+00:00monthlyhttp://crossborderbiotech.ca/daily1.02012-05-31T17:57:05+00:00